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The aim of this thesis was to evaluate the use of challenge tests in occupational rhinitis 
(OR) diagnostics, to study the long-term health-related quality of life among allergic OR 
patients, and to study the allergens of wheat grain among occupational respiratory allergy 
patients. OR is a rhinitis mainly caused by work environment and not to stimuli 
encountered outside the workplace. It is different from work-exacerbated rhinitis, which is 
pre-existing or concurrent (allergic or non-allergic) rhinitis that are worsened by, but not 
mainly caused by, workplace exposures. OR can develop in response to allergens, inhaled 
irritants, or corrosive gases.  
Methods 
The thesis work consists of two retrospective analyses of patient files examined by either 
nasal provocation test (NPT, 165 patients) or by an inhalation challenge test (ICT, 829 
patients). The causative agents and their provocation test results were retrospectively 
reviewed and nasal provocation test scoring positivity used and nasal secretion amount ≥ 
0.2 g were compared in the results.  
 
A cross-sectional questionnaire study was sent to 212 consecutive patients with 
allergic OR and to 414 controls. The study evaluated health-related quality of life 
(Rhinasthma and RAND-36 questionnaires), continuing allergen exposure, employment 
and possible re-education due to OR on average 10 years after the diagnosis.  
 
Salt-soluble wheat proteins were purified using chromatographic methods and 
separated with gel electrophoresis. Serum from patients with baker’s rhinitis, asthma, or 
both was immunoblotted with these proteins and the immunodetected proteins were 
characterized by tandem mass spectrometry. Skin prick tests (SPTs) were used to find out 
the relevance of the allergens among patients with baker’s rhinitis or asthma to wheat.  
Results 
The diagnosed OR was mainly allergic rhinitis and the main causative occupational agents 
were flours and animal allergens. The non-IgE-mediated rhinitis reactions were less 
frequent in our challenge tests. Forty-seven percent of the patients tested with NPT 
(77/164) were diagnosed as having occupational rhinitis. The NPT was positive in 39% of 
the provocations done with occupational agents (125/318), whereas in 10% (19/193) 




challenge tests 111/117 had ≥ 0.2 g secretion amount. 302/303 nasal provocation tests the 
secretion had been < 0.2 g and the provocation test result was regarded as negative. In OR 
cases there was a clear difference between the occupational and placebo provocation tests. 
In the ICTs evaluated, rhinitis appeared in 13% (111/829) of challenged patients, while 
asthmatic reactions appeared in 25% of these patients. The placebo tests gave 2% positive 
rhinitis reactions in the ICTs. The tested agents were only partially similar in the ICT and 
NPT.  
 
Continuing allergen exposure was related to decreased HRQoL on average 10 years 
after the diagnosis among patients with allergic OR, despite the use of rhinitis 
medications. The HRQoL of the patients, who were not occupationally exposed any 
longer, had a HRQoL mainly comparable to the healthy controls. The long-term 
employment rate was similar among the Finnish OR patients and the controls, but 17% of 
the OR patients had had re-education due to their OR.  
 
Several wheat allergens were identified and purified and their clinical relevance was 
tested with skin prick tests. They included two new allergens that were found as clinically 
relevant with baker's rhinitis and asthma.  
Conclusions 
Both nasal challenges and inhalation challenges were found to be safe tests, as no serious 
reactions or anaphylactic reactions have appeared in the tests in our institute. The 
inhalation challenge tests have considerably resource-intensive methodology. However, if 
both upper and lower airway studies are needed, the evaluation of nasal symptoms and 
signs together with bronchial reactions saves time and expense compared with the 
organization of multiple individual challenges. The scoring criteria used matched well 
with the weighted amount of discharge ≥ 0.2 g and in most cases gave comparable results. 
The challenge tests are valuable tools when there is uncertainty whether the patient's 
exposure should be discontinued or he or she should change job. However in non-IgE 
related rhinitis the specific mechanisms are often unknown and mostly the non-IgE-
mediated agents cause more often asthma than rhinitis. The rhinitis reactions may be 
milder than in IgE-mediated rhinitis and therefore they may be more difficult to recognize. 
There is still need to find out the most relevant methods for non-IgE mediated rhinitis.  
 
We found that continuing exposure decreases HRQoL among patients with allergic OR 
despite of rhinitis medications still approximately ten years after the diagnosis. HRQoL 
among OR patients without any longer occupational exposure were mainly similar than 
that of the healthy controls. This highlights the importance of the reduction and cessation 






The knowledge of the new clinically relevant proteins can be used in the future in the 





Tiivistelmä (Summary in Finnish) 
Tavoitteet 
 
Väitöskirjatyön tavoitteena oli arvioida ammattinuhan altistuskoemenetelmiä, selvittää 
allergiseen ammattinuhaan sairastuneiden pitkäaikaista elämänlaatua sekä kartoittaa 
ammattinuhan yhden pääaiheuttajan, vehnän, allergeeneja vehnäallergista jauhonuhaa tai -
astmaa sairastavilta potilailta. Ammattinuhalla tarkoitetaan työssä esiintyvän tekijän 
pääasiallisesti aiheuttamaa nuhaa. Se tulee erottaa työn pahentamasta, (tai samanaikaisesta 
muusta) nuhasta, jossa työympäristö siis ei ole pääasiallinen nuhan syy.  
Päämenetelmät 
Väitöskirjatyössä tehtiin kaksi takautuvaa tutkimusta ammattinuhaan sairastuneiden 
potilaiden potilastiedoista, joita oli diagnosoitu työperäisin altistustestein 
(nenäaltistustestein 165 ja kammioaltistustestein 829 potilasta). Ammattinuhan aiheuttajat 
ja altistuskoetestitulokset arvioitiin takautuvasti ja käytettyä nenäaltistuskokeiden 
(pisteytys) positiivisuutta verrattiin ≥ 0.2 g nenän eritemäärän kriteeriin.  
 
Keskimäärin kymmenen vuotta aiemmin diagnosoiduille 212 allergista ammattinuhaa 
sairastavalle potilaalle, sekä 414 iän ja sukupuolen suhteen samankaltaiselle 
satunnaistetulle verrokkihenkilölle tehtiin postitse kyselytutkimus. Kysely selvitti 
terveyteen liittyvää elämänlaatua (RAND-36 ja Rhinasthma), potilaiden altistumisen 
jatkumista, työssäkäyntiä ja mahdollista uudelleenkoulutusta.  
 
Vehnän vesiliukoisia valkuaisaineita puhdistettiin ja eroteltiin (geelifiltraatio, 
kromatografiat) sekä tunnistettiin leipurin nuhan ja astman allergeeneiksi potilasseerumien 
avulla (SDS-PAGE, massaspektrometria). Tunnistettujen proteiinien merkitystä 
allergeeneina tutkittiin ihopistotestien avulla 20 työssään vehnälle allergisilla 
nuha/astmapotilaalla ja 10 terveellä verrokkihenkilöllä.  
Saavutetut tulokset 
Todetut ammattinuhat olivat yleensä allergista nuhaa, ja tavallisimmat ammattinuhan 
aiheuttajia olivat jauhot ja eläimet. Ei-allergista nuhaa tuli testeissä esiin selvästi 
harvemmin kuin IgE-välitteistä allergiaa. Ammattinuha todettiin 47% (77/164) 
nenäaltistustestein tutkituista potilaista. Työperäisillä aineilla tehdyistä 
nenäaltistuskokeista 39% (125/318) oli testipositiivisia, kun taas lumeaineella tehdyistä 




työperäisen ja lumealtistuksen tuloksen välillä. Positiiviseksi luokitelluissa 
nenäaltistuskokeissa oli 111/117 ≥ 0.2 g eritysmäärä. Negatiiviseksi luokitelluissa 
altistuskokeissa eritemäärä oli < 0.2 g 302/303 testissä.  Kammioaltistustesteissä 13% 
(111/829) potilaalle tuli positiivisen testin kriteerit täyttävä nuhaoireisto, kun taas 
astmareaktiot olivat yleisempiä (25%). Kammioaltistuksien lumetesteistä 2% aiheutti 
nuhareaktion. Nenä- ja kammioaltistuksissa testatut aineet olivat vain osittain samoja.  
 
Jos työperäinen altistuminen allergeeneille jatkui noin 10 vuotta ammattinuhan 
diagnosoinnin jälkeen, terveyteen liittyvä elämänlaatu oli ammattinuhaan sairastuneilla 
alentunut, nuhalääkityksestä huolimatta. Ei-altistuvien potilaiden elämänlaatu oli pääosin 
samankaltainen kuin terveillä ei-allergisilla verrokkihenkilöillä. Ammattinuhapotilaat ja 
verrokkihenkilöt eivät eronneet toisistaan työssäkäynnin suhteen, mutta merkittävä osa (17 
%) ammattinuhapotilaista oli ammattitaudin takia uudelleenkoulutettuja.  
 
Useita vesiliukoisia allergeeneja puhdistettiin vehnästä ja tunnistettiin. Niiden 
merkitystä hengitystieallergeeneina tutkittiin leipurin nuhaa ja / astmaa sairastavilla 
vehnäallergisilla potilailla ihopistotestein. Tutkimuksessa löydettiin kaksi uutta 
merkityksellistä vehnän allergeenia leipurin ammattinuhassa ja/ tai astmassa.  
Johtopäätökset 
Työperäisillä aineilla tehtävät nenä- ja kammioaltistuskokeet todettiin analyyseissä 
turvallisiksi testeiksi, koska vakavia, vaikeasti hoidettavia allergiareaktioita ei niissä ollut 
esiintynyt Työterveyslaitoksen historiassa. Altistustestit ovat arvokkaita, kun on 
epävarmaa voiko altistuminen jatkua tai tuleeko potilaan vaihtaa työtä. 
Työterveyslaitoksen käyttämä pisteytyskriteeri antoi pääasiassa yhteneväisen tuloksen 
eritemittauksen kanssa, joka tukee oletusta eri testimenetelmien pääosin yhteneväisistä 
tuloksista työperäisen allergian testauksissa. Vaikka kammioaltistuskoe vaatii paljon 
resursseja, voidaan kammioaltistuksessa yhdistää keuhkoputkialtistus ja nenäaltistus, mikä 
säästää aikaa ja kustannuksia verrattuna kahteen eri tutkimukseen. Ammattinuhat ovat 
pääosin allergista nuhaa. Ei-allergisten ammattinuhan aiheuttajien osalta nuhan 
mekanismit ovat pääosin tuntemattomia, ja näiden pääasiassa ns. pienimolekyylisten 
aineiden suhteen astmareaktiot ovat tavallisempia löydöksiä kuin nuhat altistuskokeissa. 
Nuhareaktiot voivat olla myös lievempiä kuin allergisessa nuhassa, jonka takia niitä voi 
olla vaikeampi tunnistaa. Ei-allergisen nuhaan sopivimpien tutkimusmetodien löytämiseen 
on edelleen tarvetta.  
 
Koska altistumisen jatkumisen todettiin olevan yhteydessä terveyteen liittyvään 
elämänlaadun alentumiseen vuosienkin kuluttua diagnoosista nuhalääkityksestä 
huolimatta ja altistumisen loputtua terveyteen liittyvä elämänlaatu oli pääosin samanlainen 
kuin terveillä verrokkihenkilöillä, väitöstutkimus korostaa altistumisen vähentämisen tai 
lopetuksen tarvetta ammattinuhapotilailla. Altistumisen vähentämisen mahdollistamiseksi 




Tietoa uusista vehnän työperäistä hengitystieallergiaa aiheuttavia merkittävistä 
valkuaisaineista voidaan jatkossa hyödyntää kehitettäessä leipurin nuhaa ja astmaa 







“When you come to a patient’s house, you should ask him what sort of pains he has, what 
caused them, how many days he has been ill, whether the bowels are working and what 
sort of food he eats.” So says Hippocrates in his work Affections. I may venture to add one 
more question: what occupation does he follow? says Bernardino Ramazzini 1700 in 
Diseases of Workers, Preface (Salvaggio, 1990; Erensen, 2009).  
 
Today occupational rhinitis (OR) is linked to the fields of occupational medicine, 
otolaryngology, allergology and immunology, toxicology and industrial hygiene. The 
compensation and measures of rehabilitation are dependent on the insurance companies' 
acceptance. In addition both the OR diagnostics as well as the decisions of the insurance 
companies are guided by the legislation.  
 
This thesis work was started from the need to update the knowledge of OR diagnostics 
results with challenge tests, causative allergens and agents and the sensitivity of the tests 
in order to improve the efficacy of the Otorhinolaryngology (ORL) work field in our 
institute. All the challenge test agents used during the study and the test results both in 
nasal and inhalation challenge tests had not been assessed recently, and the inhalation 
challenge test had not been previously evaluated at all to our knowledge.  In addition, 
there is a long-lasting need for a comparison of the various criteria of challenge tests, as 
there are various nasal challenge test methods which are not harmonized. The study 
describes and characterizes diagnostics of OR cases in Finnish institute of Occupational 
Health, and the role of provocation tests in it.  
 
Occupational diseases have a fundamental role for the patients, as these diseases can 
be a direct threat to ones decreased income, unlike with most diseases. As physicians 
examining these patients, we wanted to find the impact on the OR to the patients' long-
term health-related quality of life and livelihood, as these aspects had not been previously 
evaluated and as major changes in work like relocation or re-education are often needed 






2 Review of the literature 
2.1 Definitions of rhinitis 
Rhinitis is defined as an inflammation of the lining of the nose, and it is characterized by 
nasal symptoms including anterior or posterior rhinorrhea, sneezing, nasal blockage and/or 
itching of the nose (International Rhinitis Management Working Group, 1994). By 
definition the symptoms occur during two or more consecutive days for more than 1 h on 
most days. Because there is no agreed international standard method to objectively 
diagnose nasal inflammation, the symptom evaluation has been assigned a great 
importance in the diagnosis of OR (Hellgren et al., 2003).  
2.2 Definition of allergic and non-allergic rhinitis 
Allergy is defined as a hypersensitivity reaction initiated by immunologic mechanisms. 
An allergy can be antibody-mediated or cell-mediated. In most patients, the antibody 
typically responsible for an allergic reaction belongs to the IgE isotype, and these patients 
may be said to suffer from IgE-mediated allergy. Inhalation of large amounts of protein, as 
in mold, grain dust, etc., stimulates the immune system to produce antibodies mainly of 
the IgG, IgA, and IgM isotype. There is a relation between degree of exposure and 
antibody concentration (Johansson et al., 2004). 
 
The European Academy of Allergy and Clinical Immunology (EAACI) position 
statement proposes that non-IgE-mediated allergic reactions be subdivided into those in 
which the reaction is initiated predominantly by mechanisms associated with allergen-
specific antibodies other than IgE, and those in which a cellular response is predominant 
(Johansson et al., 2001). The World Allergy Organization (WAO) revised nomenclature 
for allergy states that when other mechanisms than IgE can be proven behind the 
hypersensitivity, like as in hypersensitivity to aspirin, the term nonallergic hypersensitivity 
should be used (Johansson et al., 2004). 
 
Hypersensitivity, in the WAO recommendations, is suggested to be used to describe 
objectively reproducible symptoms or signs initiated by exposure to a defined stimulus at 
a dose tolerated by normal persons (Johansson et al., 2004). 
 
Allergic rhinitis (AR) is clinically defined in the World Health Organization Allergic 
Rhinitis and its Impact on Asthma (ARIA) workshop update as a symptomatic disorder of 
the nose induced after allergen exposure by an IgE-mediated reaction (Bousquet et al., 
2008). Other than IgE-mediated rhinitis reactions are defined as non-allergic rhinitis 













The diagnostic criteria are different for epidemiological studies, and the criteria used 
affect the reported prevalence. Several standardised questionnaires exist and each of them 
has different sensitivity and specificity (Charpin et al. 1996). The specificity and 
sensitivity of AR questions for the epidemiologic studies in Finnish has been studied from 
the Tuohilampi questionnaire (Susitaival and Husman, 1996). A question of "were you 
told by a doctor that you have hay fever or nasal allergy" has a specificity of 0.93 and 
sensitivity of 0.52, as compared to symptoms of AR during the preceding year at 
interviews by the chest physician and at least one wheal reaction with a mean diameter of 
at least 3 mm in SPT and/or specific IgE test (Phadiatop combi) greater than 0.35 kU/l 
(Kilpeläinen et al., 2001).  
2.3 Definitions of occupational rhinitis 
The classification of occupational rhinitis (OR) has been recently revised after an initiative 
to evaluate the definition and the classification in the scientific literature (Castano and 
Theriault, 2006). An operational definition and classification of OR as well as a diagnostic 
algorithm for OR has been proposed in 2008 by the EAACI Task Force on Occupational 
Rhinitis (Moscato et al., 2008). The work has been published as an EAACI position paper 
(Moscato et al., 2009, Figure 2). They define: OR is an inflammatory disease of the nose, 
which is characterized by intermittent or persistent symptoms (i.e., nasal congestion, 
sneezing, rhinorrhea, itching), and/or variable nasal airflow limitation and/or 
hypersecretion arising out of causes and conditions attributable to a particular work 
environment and not to stimuli encountered outside the workplace.  
 






















Allergic occupational rhinitis  
Allergic occupational rhinitis has been further divided in the following way:  
1. IgE-mediated OR: can be caused by a wide variety of high molecular weight 
(HMW) agents (i.e. glycoproteins from vegetal and animal origin) and some low 
molecular weight agents (LMW) for which an IgE-mediated mechanism has been proven, 
such as platinum salts, reactive dyes, and acid anhydrides. 
2. Non-IgE-mediated OR: can be induced by LMW agents (e.g. isocyanates, 
persulphate salts, wood dusts) acting as haptens for which the allergic mechanism has not 
yet been fully characterized (Moscato et al., 2008).  
 
 
Non-allergic occupational rhinitis  
Non-allergic OR has been stated to encompass rhinitis caused by work environment 
through irritant, non-immunological mechanisms. Single or multiple exposures high 
concentrations of irritant compounds like ozone or chlorine can lead to transient or 
persistent symptoms of rhinitis (Leroyer et al., 1999; Hoffman et al., 2004). As the 
situation is much like reactive airways dysfunction syndrome (RADS), the term reactive 




Rhinitis caused by work  
= Occupational Rhinitis (OR) 
 
Rhinitis exacerbated by work 
 
Allergic OR (with latency period): 
 IgE-mediated 
 non-IgE-mediated 
Non-allergic OR (without latency): 
 Single exposure: Reactive upper airways dysfunction 
syndrome (RUDS)  
 Multiple exposures: Irritant-induced OR  




The term irritant-induced OR may also refer to symptoms of rhinitis reported by 
subjects repeatedly exposed to irritants, without identifiable high concentrations of them 
(Moscato et al., 2009).  
 
Patients with nasal septal perforations of occupational origin exhibit the clinical and 
histopathological features of rhinitis whereby they should be categorized as rhinitics. It 
has been suggested lately, that this rhinitis should be considered as a type of irritant-
induced OR and classified as corrosive rhinitis (Castano et al., 2007).  
Other definitions 
An OR definition, introduced earlier to the EAACI consensus paper has been, for 
example, the episodic work-related occurrence of sneezing, nasal discharge, and nasal 
obstruction (Bardana, 1995). The mechanisms causing OR have been classified in some 
expert opinion to heightened olfactory awareness, nonspecific inflammation of the nose, 
exposure to a high concentration of irritating and soluble chemical gases and IgE 
mechanisms (Slavin, 2003).  
 
The classification to IgE-mediated allergy and other forms of non-IgE-mediated 
immunologically mediated diseases has been somewhat inconsistent in the literature. In 
the occupational setting, the EAACI position papers on occupational rhinitis (Moscato et 
al., 2008; Moscato et al., 2009) define occupational AR to include IgE- mediated rhinitis 
and non-IgE-mediated rhinitis forms, in which immunologically mediated mechanisms are 
suspected. On the other hand, in another definition, AR is clinically defined as a 
symptomatic disorder of the nose induced after allergen exposure only by an IgE-mediated 
reaction (Bousquet et al., 2008), and those reactions other than IgE-mediated are defined 
as non-allergic rhinitis. WAO revised the nomenclature for allergy states so that when 
other mechanisms than IgE can be proven behind the hypersensitivity, like as in 
hypersensitivity to aspirin, the term nonallergic hypersensitivity should be used 
(Johansson et al., 2004). 
 
The Finnish OR statistics consider both IgE and non-IgE-mediated forms as AR and 
allergic respiratory diseases in the yearly reports (Karjalainen et al., 2001b). The non-
allergic OR (without latency) cases diagnosed in Finland have been solitary cases only.  
 
The Act and Ordinance on Occupational Diseases in Finland defines OR as a disease 
probably primarily and mainly caused by any physical factor, chemical substance or 
biological agent at work, encountered in the course of work done under contract of 
employment, in the public service or in public office or as an agricultural entrepreneur 





2.4 Causes of occupational rhinitis 
The etiological agents causing OR have been extensively reviewed (Siracusa et al., 2000; 
van Kampen et al., 2000), and the various occupations relative risk of OR in Finland 
during 1986-1991 have been analyzed from the Finnish Register of Occupational Diseases 
and Finnish censuses as well (Hytönen et al., 1997). 
Flours and foods as a cause of occupational rhinitis 
The most common cause of OR in Finland is flour dust (Karjalainen et al., 2008). The 
flour dust means dust from finely milled or otherwise processed cereal. Cereal allergens, 
that spread through the air and inhaled can cause occupational inhalation allergy. Flours 
are the main cause of baker's rhinitis (and baker's asthma), and specific IgE is most often 
found in baker's rhinitis against wheat, rye, barley or oats. These species are 
taxonomically closely related and there is strong cross-antigenity between them (Baldo et 
al., 1980; Sandiford et al., 1995). Wheat is one of the most commonly used flour in the 
western world and the main cause of baker's rhinitis and asthma in these countries 
(Brisman, 2002). Other reported flours that have been stated as causes of OR are maize 
(Borghesan and Borghesan, 2005), corn dust (Park and Nahm, 1997), lupine flour 
(Campbell et al., 2007) soybean and other botanically relative legumes (De Zotti et al., 
1988; Martinez San Ireneo et al., 2000). In addition, other baking ingredients, spices, 
enzymes, other additives, mold, insects, mites and other contaminations of foodstuffs can 
cause allergy or irritation rhinitis (Brisman, 2002).  
 
Other food causing OR have been for example: clam and shrimp (Desjardins et al., 
1995), lobster (Lemiere et al., 1996), milk proteins (Toskala et al., 2004), egg proteins 
(Leser et al., 2001), mushrooms (Symington et al., 1981) and seeds (Keskinen et al., 1991; 
Vandenplas et al., 1998).  
Occupational wheat allergens  
There are nine characterized allergens in wheat seed (Tri a 14 non-specific lipid transfer 
protein 1, Tri a 18 agglutinin isoleucin 1, Tri a 19 omega-5 gliadin, Tri a 25 thioredoxin, 
Tri a 26 glutenin, Tri a 27 thiol reductase homologue, Tri a 28 dimeric alpha-amylase 
inhibitor 0.19, Tri a 29 tetrameric alpha-amylase inhibitor CM1/CM2, Tri a 30 tetrameric 
alpha-amylase/trypsin inhibitor CM3), accepted on the International Union of 
Immunological Societies (IUIS) Allergen Nomenclature sub-committee list of certified 
protein allergens. They are listed on the website www.allergen.org (Marsh et al., 1986). In 
addition there other wheat allergens introduced (e.g. Weiss et al., 1993; Garcia-Casado et 
al., 1996; (Sanchez-Monge et al., 1997) and some new recently (Constantin et al., 2009, 
de Gregorio et al., 2009) and most of them are included in other web-base allergen 





Animal proteins as a cause of occupational rhinitis 
Cattle are among the leading causes of occupational rhinitis (OR) (Heutelbeck et al., 
2007). In farm surroundings storage mites are also often relevant allergens (Terho et al., 
1987). Nowadays several laboratory animal derived dusts, especially from mice and rats 
are frequent causes of OR (Bush and Stave, 2003). Some other OR cases has been 
reported to roe deer (Carballada et al., 2006) and to goat (Ferrer et al., 2006). Various 
insects, mites, spiders, flies, cockroaches and worms are also well-recognized causes of 
OR. 
Other organic causes of occupational rhinitis 
Earlier, natural rubber latex, mainly in powdered gloves, has been an important allergen 
especially in health care. The development of less allergenic gloves has greatly decreased 
the problem. Various enzymes are important and potent causes of OR and their inhalative 
uptake should be avoided (Baur, 2005). Plant pollens, plant and seed dust may cause 
sensitization and OR in persons handling them at work (Martinez San Ireneo et al., 2000; 
Groenewoud et al., 2002). For example various beans and legumes have been reported to 
cause OR (Osterman et al., 1982; Codina et al., 2000; Daroca et al., 2000; Martinez San 
Ireneo et al., 2000). Wood-derived natural rubber latex, obeche and red cedar, and some 
other wood dusts are known as sensitizing causes of OR. Some molds can cause IgE-
mediated occupational rhinitis (Merget et al., 2008), but yet molds have been found only 
rarely causing sensitization, and that sensitization to them is likely associated to other 
allergies (Reijula et al., 2003). In addition some hard wood dusts are causes of nasal 
irritation that may lead to occupational carcinogenesis (Alberty et al., 2009).  
Inorganic causes of occupational rhinitis 
Among the first studies of occupational inorganic rhinitis were studies from 1941-1955 of 
paraphenylenediamine, a chemical used in hair and fur dying, that was found to be a cause 
of occupational rhinitis (Silberman and Sorrell, 1959). Some other chemicals causing 
occupational rhinitis (OR) are for example various isocyanate-derivatives (Baur et al., 
1984; Baur et al., 2001), persulphate (Moscato et al., 2005), thioglycolates (Leino et al., 
1998), formaldehyde, that can also exert nasal irritant reactions (Pazdrak et al., 1993), 
glutaraldehyde (Palczynski et al., 2001), newly found component tolyltriazole in metal-
cutting fluids (Graff et al., 2008), methacrylates and cyanoacrylates (Weytjens et al., 
1999; Torres et al., 2005). 
 
Organic acid anhydrides are potent sensitizers and potent causes of OR as well as 
asthma (Kimber and Dearman, 2002) like reactive dyes (Alanko et al., 1978; Nilsson et 
al., 1993), henna (Majoie and Bruynzeel, 1996), some metals (Cristaudo et al., 2005; 
Malo, 2005), medicaments (Malet et al., 1992; Moscato et al., 1995) and disinfectant 




(Burge et al., 1984), ninhydrin (Piirila et al., 1997) and benzisothiazolin-3-one have also 
been reported (Moscato et al., 1997).  
2.5 Diagnosis of occupational rhinitis  
Legislation in Finland  
The decree on Occupational Diseases in Finland defines that the diagnosis of occupational 
disease requires medical examination where there is a sufficient knowledge of the 
exposure at work and a medical doctor familiar with occupational diseases diagnostics in 
charge (Finnish Ministry of Social Affairs and Health, 1989b). 
 
The decree lists for example the following chemical factors where rhinitis or irritation 
of mucous membranes is given as one of the typical forms of diseases:  
 cobalt and its compounds as allergens 
 chromium and its compounds as allergens or as local irritative/ corrosive cause 
of rhinitis or as causes of cancer of nasal sinuses  
 nickel and its compounds as allergens causing rhinitis or as cause of cancer of 
the nasal sinuses 
 chlorine, chromine bromine, fluorine as irritants and corrosive to mucous 
membranes 
 cyano compounds: respiratory diseases caused by isocyanates  
 sulfur dioxide and sulfur acid as irritatives and as causing inflammatory 
symptoms of mucous membranes 
 nitrogen oxide, nitric acid and ammonia as acute irritants of respiratory tract 
 inorganic bases and their anhydrides as causes of acute corrosion symptoms of 
mucous membranes 
 halogenated derivates of hydrocarbons: irritative respiratory symptoms caused 
by freons 
 rhinitis caused by formaldehyde 
 respiratory allergies caused by antibiotics 
 
The decree names the following agents as causes of rhinitis without definition of the 
causative mechanism:  
 plastics and the synthetic resins and the substances and intermediates involved 
in their production  
 organic acids and acid anhydrides  






The decree of occupational diseases states also, that occupational rhinitis can be 
caused by  
 organic dusts, i.e. flours, grain, wood dusts and materials, animal dander and 
other exposures of animal origin, dusts of organic fibres, enzymes, natural 
resins like colophony, natural rubber latex.  
 
The disease is considered to have begun during the time the patient has first sought 
medical help from a doctor because of the occupational disease symptoms.  
Occupational exposure limits in Finland  
 
The Finnish Ministry of Social Affairs and Health publishes maintains and updates the 
Finnish occupational exposure limit (OEL) value lists, which is a list of concentrations of 
impurities in workplace air, that are known to be hazardous (HTP values in Finnish) to the 
workforces safety, health or breeding health. They are confirmed by the law and Act of 
safety at work in Finland (Finnish Ministry of Social Affairs and Health, 2002) and the 
related publications are renewed frequently (Finnish Ministry of Social Affairs and 
Health, 2009). The effects that the exposure may cause to sensitive groups (e.g. atopics or 
various patient groups) are usually not taken into account while the limits have been set, 
so they need to be considered separately.  
 
Irritation of skin, eyes and airways by the impurities of workplace air has been taken 
into account in the values of the OEL values. The Finnish OELs are values which the 
employer needs to pay attention to while assessing the worker's exposure to air impurities.  
 
The harmful or hazardous effects of air impurities depend on their concentration and 
on exposure time. Therefore, the OELs are confirmed for the time-weighted averages for 8 
hours, 15 minutes and/ or momentary exposures.  
 
According to the OEL values 2009 (www.ketsu.net/htp/HTP2009.pdf), the following 
titles relevant to OR are to be updated in 2011:  
 Flours, grain dusts: airways sensitization  
 Wood dust: airways sensitization and airways irritation 
 Endotoxines: irritation and other effects on airways 
 Enzymes: airways sensitization 
 Inhaled dust: effect on airways 





Medical history and exposure at work  
The purpose of the medical history is to confirm the existence of rhinitis and to evaluate 
the link to work.  
 
The medical and work history covers  
1) The types and amounts of the exposures at work, their potential to sensitize or 
irritate the airway mucosa. In Finland, the airway sensitization knowledge of the agents 
used in the workplace and in the case of chemicals, their related safety data sheets are due 
to be available in the workplace (Finnish Ministry of Social Affairs and Health, 2001). 
2) Latency of rhinitis after the beginning of the exposure  
3) Individual medications and other diseases history 
4) Individual symptoms of rhinitis (rhinorrhea, sniffing, nasal stuffiness, nasal itch), 
their intensity, time-scale and relation to work and various exposures 
 
In addition nasal examination and related tests are needed to exclude bacterial 
sinusitis and other obvious non-occupational causes of rhinitis behind the symptoms.  
Immunological tests in occupational rhinitis diagnostics 
Skin prick test, Prick-prick test 
The sensitization to occupational agents can be tested by means of skin prick test (SPT) or 
/and assessment of serum allergen-specific IgE antibodies. The different criteria for the 
positivity have been used in various studies. In Finland national guidelines have been 
made for the interpretation of the test results (Juntunen-Backman et al., 1995). In this 
recommendation, the mean skin wheal diameter needs to be ≥ 3 mm and or larger than 
histamine wheal, that needs to be ≥ 3 mm. In an EAACI position paper, a SPT is 
considered to be positive when the mean wheal diameter is > 3 mm (area > 7 mm) 
(Mailing, 1993). A criterion that relates the allergen wheal to the size of a histamine wheal 
can compensate for the differences for prick observer differences and is appropriate for 
epidemiological studies especially for children (Meinert et al., 1994). A positive 
immunological test may appear in a substantial proportion of exposed asymptomatic 
individuals. On the other hand, negative test results make the diagnosis of IgE-mediated 
OR unlikely, provided that appropriate allergens have been tested. The main limitation of 
immunological tests in the investigation of occupational allergy results from the lack of 
standardized, commercially available extracts, especially LMW agents (Moscato et al., 
2008). Prick-prick tests have been introduced due to the poor standardization of food 
extracts commonly available. In prick-prick test the lancet pricks the food item first and 
after that the same lancet thus containing food material is used for skin prick test. These 
tests are used in situations for which the common commercial test agents are not available, 




The SPT with individual flour extracts has been shown to be superior to commercially 
available SPT solutions to rye or wheat flours in the diagnosis of occupational inhalant 
allergies (Tasman et al., 1999). A small study has shown that results of the prick-prick 
method give comparable results and are faster and less expensive compared to traditional 
SPT method (Zawodniak et al., 2003).  
Specific IgE detection: ImmunoCAP, ELISA, Immunospot  
Specific IgE detection from the sera has been classically made by a radioallergosorbent 
test (RAST), but a superior test named ImmunoCAP has replaced it with wider 
sensitivity and specificity (Leimgruber et al., 1991). Dot blot (immunospot) has also been 
at times used in the detection of specific IgE-reactions. The Immunospot assay is based on 
a modified version of the Enzyme ImmunoAssay (EIA or ELISA) technique used to detect 
the presence of an allergen in a sample. In EIA, an unknown amount of antigen is affixed 
to a surface, and then a specific antibody is washed over the surface so that it can bind to 
the antigen. This antibody is linked to an enzyme, and in the final step, a substance is 
added so that the enzyme can convert to some detectable signal (Paulie et al., 2006).  
Rhinitis provocation tests 
The main indications for using the nasal provocation test (NPT) are the assessment of 
allergic symptoms in both OR and immunotherapy. NPT has also been used for the 
diagnosis of nonallergic OR caused by irritating occupational substances (Malm et al., 
2000; Gosepath et al., 2005), for a diagnosis of acetylic salicylic acid (ASA)-induced 
asthma (Milewski et al., 1998), for rhinitis medication studies (Andersson et al., 1991) as 
well as for research (Baroody et al., 2008). As the diagnosis of OR has substantial 
financial and work-related consequences, the relationship with the work exposure needs to 
be ascertained with provocation tests (Moscato et al., 2009). 
Provocation test criteria 
There are no uniformly accepted criteria for the evaluation of nasal provocation test 
reactions (Moscato et al., 2009). In addition, the test has been done either unilaterally or 
bilaterally.  
 
Various symptoms and findings have been traditionally used as the main criteria of the 
positivity of nasal provocation test reactions. For example, the sneeze count, inspected 
nasal blockage (congestion), itching or burning of the nose, palate or throat and 
lacrimation have been used (Milewski et al., 1998) or symptom score of nasal itching, 
sneezing, and rhinoscopic nasal obstruction, rhinorrhea, and mucosal oedema (Moscato et 
al., 2005). Various symptom scores from 1976-1994 are summarized in a Finnish thesis 




rhinorrhea as the main criteria for the diagnosis of OR since the 1970's (Hytönen and Sala, 
1996). Before that symptom score with unilateral itching, swelling of the mucosa, watery 
discharge or sneezing was used. It included criteria that test with physiological saline in 
another nostril and another provocation test with lactose or saline were considered as 
negative (Kanerva and Vaheri, 1993). EAACI position paper of provocation tests and of 
occupational rhinitis state that there is general agreement that both subjective and 
objective indices must be considered (Melillo et al., 1997; Moscato et al., 2009).  
 
Various objective instruments have been introduced to value the nasal reactions. 
Acoustic rhinometry and anterior rhinomanometry have been the main tools in the hands 
of rhinologists. In acoustic rhinometry, a minimum cross-sectional area of the nose has 
been used often, as well as total nasal volume from 1 to 5 cm (Litvyakova and Baraniuk, 
2001; Hilberg, 2002; Kim et al., 2006). Recently, nasal volume from 2-5 cm depth has 
been recommended for the criteria evaluation for nasal mucosal reactions (Clement and 
Gordts, 2005). In addition, nasal peak inspiratory flow, as well as optical rhinometry and 
rhinostereometry have been introduced for the evaluation of nasal provocation results 
(Hallen and Graf, 1999; Wustenberg et al., 2004).  
 
Measurement of secretion has been introduced as one objective and relevant 
measurement of NPT, and in a unilateral test, it has shown to be slightly superior to 
acoustic rhinometry and rhinomanometry (Pirilä and Nuutinen, 1998).  
 
In healthy normal controls, the baseline nasal reactivity is rather low (Baroody et al., 
1999), but the baseline characteristics vary in various study populations. In one study with 
ASA-intolerant asthmatics, baseline nasal reactivity with rhinomanometrically measured 
fluctuation of the nasal flow > 40% before the test or total nasal obstruction excluded 19.6 
% of the study population (Milewski et al., 1998). By contrast to bronchial hyperreactivity 
in asthma, nasal hyperreactivity is scantly documented in OR so far (Moscato et al., 
2009).  
Challenge test methods 
The nasal challenge test is the standard test to confirm the causative role of a specific 
agent and a rhinitis reaction. In nasal challenge tests, the exposure agent can be applied to 
either one or both nostrils by dropping, spraying, direct application, sniffing or with 
special devices. Inhalation challenge tests are seldom reported to be used in the diagnosis 
of OR, but it is a valuable method in the simultaneous evaluation of patients with both 
lower and upper airways symptoms (Moscato, et al. 2005, Castano et al., 2009). In special 
cases workplace challenges are an option that might be considered when specific 
challenges are not possible, although the difficulty of standardization and therefore lack of 




2.6 Prevalence and incidence of occupational rhinitis 
There is very limited data on the statistics of occupational diseases available from Finland 
before occupational diseases have been compiled since 1964. It has been possible to study 
the risk of various occupations for OR from those statistics (Hytönen et al., 1997). 
Occupations with a high level of dust, as well as sensitizing exposure levels in the air can 
be considered as risk areas for OR (Hytönen et al., 1997, Riu, et al. 2007).  
 
The methods used for the definition (questionnaire, objective evaluations), baseline 
characteristics of population studied (like age and atopy) exposure time, type and exposure 
concentration in the air all affect to the results of OR prevalence and incidence. Most 
epidemiologic studies are done with symptom questionnaires, some also with specific IgE 
measurements, and a few studies have used challenge tests for confirming the causative 
role of the suspected occupational agent. The prevalence of OR may be overestimated or 
underestimated (healthy worker effect), making analysis and comparison of results 
difficult. An extensive review of the prevalence and determinants of occupational rhinitis 
has been published some years ago (Siracusa et al., 2000). The prevalence of OR in 
occupations with HMW exposure varied from 2% to 87% and with LMW agents from 3 to 
48%. Incidence of OR has been reviewed to be between 0.3 to 13.1 x100 person years 
(Moscato et al., 2009). Some more recent incidence/prevalence studies not included in 




Table 1. Some recent incidence /prevalence studies of OR. Studies that have been confirmed with 
a specific IgE tests or challenge tests are marked with*. 
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There are only limited data available on the longitudinal incidence of occupational 
respiratory diseases. In the report of Folletti et al. it was suggested that occupational 
allergic asthma due to laboratory animals has been declined progressively from 1976 to 
2001 from 8.2% to 4.2%, and it may be due to the reduction of the exposure (Folletti et 
al., 2008). They concluded that OR is three times more frequent than occupational asthma 
and that it seems that further reduction of the exposure would be needed in to prevent the 
onset of OR.  
 
In Finland, the reports of allergic OR reported to the Register of Occupational Diseases 
has declined from the end of 80's 400 cases/ year to around 100-150 until the end of 2003, 
and has not increased from that since then. There is decrease in all the main causative 
agents: flours, animals, mites, molds and wood dusts (Vaaranen et al. 1989, Karjalainen et 
al., 1996, Karjalainen et al., 1998a, Karjalainen et al., 1998b, Karjalainen et al., 2001b; a; 
Karjalainen et al., 2002; Riihimäki et al., 2003; Laakkonen et al., 2007; Karjalainen et al., 
2008). As there have been changes in the registration and notification practices Finnish 
Register of Occupational Diseases, the statistics from 2005 on are not fully comparable to 




2.7 Health-related quality of life in occupational rhinitis  
Definitions 
The Health-related quality of life (HRQoL) questionnaires indicate self-assessed impact of 
ill-health and diseases on functioning and well-being (Laaksonen et al., 2006). Various 
questionnaires can be used to measure cross-sectional differences in quality of life 
between patients at a point in time (discriminative instruments) or longitudinal changes in 
HRQoL within patients during a period of time (evaluative instruments). Both 
discriminative and evaluative instruments must be valid (really measuring what they are 
supposed to measure) and have a high test-retest reliability and responsiveness. Two basic 
approaches to quality of life measurement are available: generic instruments that provide a 
summary of HRQoL and specific instruments that focus on problems associated with 
single disease states, patient groups, or areas of function. Generic instruments include 
health profiles and instruments that generate health utilities (Guyatt et al., 1993). 
Rhinitis-specific quality of life questionnaires  
There are several disease-specific instruments designed for the evaluation of rhinitis, like 
the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) (Juniper et al., 1999), the 
mini Rhinoconjunctivitis Quality of Life Questionnaire (Anderson et al., 1999; Juniper et 
al., 2000) and the Sinonasal Outcome Test -16 (SNOT-16) (Anderson et al., 1999). 
However, as OR has a mostly allergic origin, the questionnaires addressing AR seem to be 
more relevant than the questionnaires addressing sinusitis and/or nasal polyposis. Because 
asthma and rhinitis often coexist, a specific Rhinasthma questionnaire has been designed 
to cover the rhinoconjunctivitis-asthma HRQoL comorbidity (Baiardini et al., 2003). As 
most allergic patients experience symptoms from multiple organs, disease-specific 
HRQoL measures used alone may be deficient. In a study with the rhinoconjunctivitis 
specific questionnaire RQLQ and generic questionnaire 15D, the general HRQoL 
instrument scores generated a more comprehensive view of the impact of allergen 
exposure on a patient's quality of life than RQLQ (Petersen et al., 2008).  
General health-related quality of life questionnaires 
Correlations between conventional nasal symptom-severity diaries and health-related 
quality of life have been found to be only weak to moderate. Therefore, to get an overall 
picture of a patient's health status, it is essential to measure quality of life. General health-
status questionnaires are able to compare burden of illness across different medical 
conditions. The most commonly used and the most validated generic instruments are the 
Sickness Impact Profile, the SF-36, and the Nottingham Health Profile (Juniper, 1997). 




distributed with names RAND-36 Item Health Survey 1.0 and RAND-36 Health Status 
Inventory, with minor differences in scoring (Coons et al., 2000). RAND-36 is also freely 
available and validated to the Finnish population as well as to various other cultures. In 
the health economic studies, however, preference-based HRQoL measures can be used 
that produce a single summary score covering the whole HRQoL for the comparison of 
the impact of various diseases to each other (Räsänen et al., 2006). Some examples of 
them are EQ-5D, Assessment of Quality of Life (AQoL) and 15D (Sintonen, 2001).  
Quality of life in occupational rhinitis 
Allergic rhinitis is known to impair HRQoL (Bousquet et al., 1994; Larsson et al., 2007). 
It is known that AR generally impairs the well-being of the patients, and that it affects 
social life, sleep, school and work. In a study with seasonal (SAR) or perennial allergic 
rhinitis (PAR) from adult population from England, 22% of PAR sufferers and 11% of 
SAR sufferers described their condition as annoying or disrupting to everyday life, and ≥ 
33% of all patients reported their symptoms occasionally or frequently affecting their 
home or social life (Scadding et al., 2000).  
 
The HRQoL has been studied in an occupational setting only in a minor group of the 
patients, the greenhouse workers (Groenewoud et al., 2006). In that study sensitization to 
bell pepper pollen had a significant negative effect on rhinitis specific quality of life 
scores. The other allergens had no effect on quality of life. Greenhouse employees scored 
higher on limitations in activities and much lower on emotional, sleeping, and practical 
problems, compared with individuals with perennial rhinitis. The general HRQoL 
questionnaires among OR patients has not previously been studied.  
Socioeconomic effect of occupational rhinitis  
The economic impact of OR has been sparsely studied. In general, the cost-of-illness 
studies separate the cost of the disease to those associated to the medical care treatment 
and to the indirect costs. Direct costs relating to AR are comprised of medical costs, 
physician visits and hospitalizations. AR causes indirect costs relating to the productivity 
loss and days lost from work. In rhinitis patients, self-reported effectiveness while 
working -assessed by a telephone survey-, has been found reduced in 44% of all kinds of 
rhinitics (Blanc et al., 2001). Indirect costs of AR arising out of productivity loss are more 
important than direct healthcare costs (Simoens and Laekeman, 2009). Also, worsening of 
associated airway diseases (sinusitis or asthma) may cause indirect costs in relation to AR 
(Ray et al., 1999; Yawn et al., 1999; Price et al., 2005). In one recent study the work 
productivity was negatively affected by some specific symptoms of AR (i.e. sneezing, 
nasal congestion, and watery eyes), sleep disturbance, and general health related quality of 





The interventions of OR aim to reduction or cessation of the exposure to the causative 
agent. If the exposure load cannot reasonably be avoided or reduced in the workplace, re-
education due to occupational diseases is discretionarily compensated by mandatory 
insurances in Finland. The influence of total avoidance of exposure in occupational 
asthma (OA) has been stated to be associated with substantial socio-economical 
consequences in Italy, where system did not guarantee prompt and automatic 
compensation for subjects with OA (Moscato et al., 1999). Of subjects with OA, 25–38% 
suffers from prolonged
 
work disruption, and 42–78% reports a substantial loss of
 
income. 
Financial consequences of OA are consistently more pronounced
 
in workers who avoid 
further exposure to the causal agent (Vandenplas et al., 2003).  
 
A recent questionnaire study among farmers in Finland has studied the effect on the 
occupational AR to their work ability (Järvenpää and Kulhua, 2008). In the questionnaire 
study, it was researched how the farmers have managed with AR and how it has affected 
their farming. Of the respondents, 19.6% could continue their work normally, 54.7% were 
able to continue their work with a mechanical full-face respirator and 14% had to stop 
working as farmers (Järvenpää and Kulhua, 2008). In addition, most of the respondents 
needed to make changes and adapt the farming livelihood to the situation (Figure 3). The 
costs of acquisition and cost of the use of motorized helmet respirators among farmers had 
been previously compensated by the insurance only if the patients have been shown to 
have OR and has bronchial hyperreactivity. Since the study showed their usefulness, they 
have become compensated also without hyperreactivity.  
 
Figure 3. The socioeconomic effect of allergic OR among farmers in Finland (Adapted from 































Risk of asthma and need of medication in occupational rhinitis 
Rhinitis and asthma are known to be closely connected diseases. The majority of patients 
with occupational asthma (OA) also suffer from OR, which most often precedes the 
development of OA (Moscato et al., 2009). Allergic rhinitis in general increases the risk of 
asthma by about three times among atopics and non-atopics and by more than five times 
among the highest IgE group (Guerra et al., 2002). The situation is quite similar in OR: in 
Finnish patients with confirmed occupational rhinitis the crude risk rate of asthma was 4.8, 
5.4 for those with occupational rhinitis accepted for compensation, and 3.7 for patients 
with unaccepted occupational rhinitis. The risk ratio varied according to occupation and 
was the highest among farmers and wood workers, both groups having a sevenfold risk 
(Karjalainen et al., 2003). Additional risk factors for asthma have been found to be 
bronchial hyperresponsiveness, and both severity and duration of rhinitis (Moscato et al., 
2009). When the potential risk factors for occupational asthma were compared among 
apprentices exposed to high-molecular weight allergens, the bronchial 
hyperresponsiveness was the most significant one, while rhinoconjunctivitis (defined as at 
least one symptom of rhinitis or conjunctivitis), atopy (defined as two or more  3 mm 
wheals in SPT) and bronchial hyperresponsiveness (provocative concentration to 
methacholine causing a change in FEV1 of 20% (PC20) of ≤ 16 mg/ml) were compared 
(Gautrin et al., 2003). 
 
Among prospective cohorts of an 8-year follow-up of 408 apprentices entering 
programs involving exposure to high-molecular-weight allergens and who held a job 
related to their training (78%), the incidence of sensitization, rhinoconjunctival and chest 
symptoms, and bronchial hyperresponsiveness at follow-up was 1.3, 1.7, 0.7, and 2.0 per 
100 person-years, respectively. A high proportion of subjects in a job not related to 
training experienced a remission of symptoms acquired during apprenticeship (Gautrin et 
al., 2008).  
 
Among the Finnish farmers with OR, the prevalence of asthma has been in a 
questionnaire study 26.8% (with response percentage of 53%), (Järvenpää and Kulhua, 
2008). The medication needed for OR has been rarely addressed. In the Finnish study 
among farmers with OR, 52.5% regularly used medication for their rhinitis, 44.7 % did 
not use medication and 2.7% did not respond (Järvenpää and Kulhua, 2008).  
2.8 Proteomic methods in allergen studies  
"Proteomics" is the large-scale screening of all proteins of a cell, organism or biological 
fluid; a process which needs stringently controlled steps of sample preparation, 2-D 
electrophoresis, image detection and analysis, spot identification and database searches 




for the IgE-mediated allergic symptoms of the patients, for the standardization and 
development of the allergy tests, immunotherapy agents and hypoallergenic plants and 
products. The biochemical methods needed and used here for detection and analysis of 
proteins from biological samples are described briefly.  
Chromatography 
Chromatography is the collective term for a family of laboratory techniques for the 
separation of mixtures. Preparative chromatography separates the components of a 
mixture for further use and is thus a form of purification. There are numerous techniques 
of chromatography, and they can be divided e.g. by the mechanism of separation (Lewis, 
2006).  
 
In exclusion chromatography, separation is based mainly on exclusion effects, such as 
differences in molecular size and/or shape or in charge. The term size-exclusion 
chromatography may also be used when separation is based on molecular size. The term 
gel filtration chromatography can be used to describe the process when the molecules in 
solution are separated according to differences in their sizes as they pass through a column 
packed with a chromatographic medium, which is a gel (GE Healthcare Bio-Sciences AB, 
2002).  
 
Chromatographic techniques are often classified by specifying the physical state of 
both phases used. Accordingly, in liquid chromatography (LC) is a separation technique in 
which the mobile phase is a liquid. Present-day liquid chromatography generally utilizing 
very small particles and a relatively high inlet pressure, is often characterized by the term 
high-performance (or high-pressure) liquid chromatography (HPLC). In reversed-phase 
HPLC, the mobile phase is significantly more polar than the stationary phase, e.g., a 
microporous silica-based material with chemically bonded alkyl chains (Sandra et al., 
2008).  
Protein immunoblot, SDS-PAGE and electrophoresis  
Protein immunoblot (also called western blot) allow investigators to define the molecular 
weight (MW) of a protein and to measure relative amounts of the protein present in 
different samples. Proteins (or their fractions) can be separated by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) according to their MW (Gorg et 
al., 1988; Berkelman and Stenstedt, 2002). SDS-PAGE maintains polypeptides in a 
denatured state once they have been treated with strong reducing agents to remove 
secondary and tertiary structure. The proteins are then moved to nitrocellulose (or other) 
membrane by electrophoresis and the IgE immunological detection can be done with 
patient sera after incubating with a general protein (like milk). During the detection 




which is linked to a reporter enzyme, which when exposed to an appropriate substrate 
drives a colour reaction. 
Mass spectrometry and bioinformatics tools 
The fingerprints of peptides of IgE binding proteins can be generated using matrix-
assisted laser desorption ionization (MALDI) tandem time-of-flight (TOF) mass 
spectrometry (MS) and identifying the proteins with the commercial databases (Akagawa 
et al., 2007). Information technology is employed in gathering, storage, retrieval and 
analysis of these data. At least a dozen important allergen databases and data repositories 
have been developed to date (Brusic et al., 2003). These data are analysed using general 
and specialist bioinformatics tools. The major applications of bioinformatics include 
support for allergen characterization, assessment of allergenity, and identification of 





3. Aims of the study 
The aim to the present thesis was to assess the diagnostics of OR in FIOH. In addition, we 
wanted to evaluate the long-term quality of life among OR patients in Finland as well as to 
study the allergens of wheat grain, the main cause of OR in Finland.  
 
The specific aims of the thesis were:  
 
I To evaluate the usefulness and clinical value of the nasal provocation tests with 
various allergens, haptens and non-IgE-mediated irritants in the diagnostics assessing 
occupational rhinitis. 
 
II To study the outcome of occupational inhalation challenge test in assessing 
occupational rhinitis in patients with a suspicion of both upper and lower airway 
occupational symptoms. 
 
III To evaluate the health-related quality of life among allergic occupational rhinitis 
patients. As a control group, a random population of similar age and locality with and 
without doctor diagnosed allergic rhinitis, was studied. 
 
 IV To characterize relevant wheat flour allergens among Finnish patients with baker's 






4. Subjects and methods 
4.1 Patients (I-IV) 
Altogether 1495 outpatient consultations were done in Finnish Institute of Occupational 
Health (FIOH) at the unit of Otorhinolaryngology in 2001-2003 because of suspected OR. 
Of these, 11 % (165 patients: 117 women and 48 men) were examined by a nasal 
provocation test (NPT) and were the subjects of the study I. The average age of these 
patients was 41 years (range 23-64 years). The inclusion criteria for performing the NPT 
were: 1) obvious exposure to a known occupational allergen or mould damage found in 
the workplace, 2) symptoms referring to work-related allergic rhinitis, 3) no other obvious 
cause for the rhinitis and 4) no contraindications for the NPT. The symptoms suggestive of 
occupational AR were episodic, work-related occurrence of nasal obstruction, rhinorrhea, 
sneezing, itching of the nose and/or postnasal drainage. In addition, sensitization against 
work-related allergen(s) was generally found, supporting the suspicion of occupational 
disease.  
 
Altogether, 3895 otolaryngology consultations were performed at FIOH in 1997–2003 
because of suspected upper airway disease. In cases where the suspected allergen was 
either chemical or the patient had both upper and lower airway symptoms related to work, 
the patients, 21% (829) in all, were examined by an inhalation challenge test. Those 
patients were the subject of the study II. The age of these patients varied between 18 and 
65 years with a mean age of 44 years. 
 
The subjects of the study III were 212 consecutive patients with occupational rhinitis 
(OR) to a protein allergen, gathered from the patient registry of the FIOH. Their inclusion 
criteria were 1) diagnosis of occupational AR to a protein allergen, 2) a visit to the clinic 
during 1991-2003 and 3) no asthma found in examinations carried out at the same time as 
OR diagnosis. Of the OR diagnoses, 93-97% had been verified by challenge tests. We had 
no access to the diagnostic case records of five (4%) patients, because they had been 
diagnosed in other hospitals. In addition, 414 controls, randomly chosen from the Finnish 
population registry, with the same age and locality, were asked to complete the 
questionnaires. For the controls, a positive answer to doctor-diagnosed AR was considered 
to indicate AR. This question has been validated and found to have specificity of 0.93 and 
sensitivity of 0.52 among Finnish young adults as compared to SPT /specific IgE 
confirmed AR (Kilpeläinen et al., 2001).  
 
The subjects of the study IV were 20 Finnish patients diagnosed with baker's rhinitis or 
baker's asthma between 4
th
 February 2004 and 31
st
 December 2007, who had subjective 
symptoms in relation to wheat exposure (Table 1). In addition to that, our inclusion 
criteria included specific IgE antibodies  0.35 to wheat flour (ImmunoCAP, Phadia, 




positive (3 mm or larger) skin prick prick test wheals to wheat flour (100 mg/ml mixed 
with 0.1 M PBS pH 7.4). In addition, 19 out of 20 of the diagnoses of bakers' rhinitis 
and/or asthma had been verified with a nasal provocation test or inhalation challenge tests 
with grains the patients were exposed to at their workplaces. Control group consisted of 10 
healthy subjects, with negative SPT reactions to wheat and common environmental 
allergens tested.  
Ethical considerations 
The study designs were approved by the local ethics committee. All clinical subjects 
participated voluntarily, and gave their written, informed consent.  
4.2 Methods 
Challenge test methods (I, II) 
In study I, the NPTs were performed like previously described (Hytönen and Sala, 1996), 
using the scoring criteria counting changes in rhinorrhea and mucosal blockage as the 
measure of positivity. Liquid allergens were applied on the topical surface of the inferior 
conchae, usually by applying a 0.1 ml allergen-saturated small piece of neurosurgical 
cotton disk (Cameco, Sweden) or, to avoid any irritation, by dropping 0.1 ml of allergen 
solution from a syringe with a metal suction head. The dry provocation agents were 
applied with the head of a nasal elevator on the topical surface of both inferior conchae. 
Changes in the rhinorrhea and blockage from both nostrils were scored from 0 to 3 points 
(from dry mucosa or mucosa lining only the bony conchae to dripping mucus or swelling 
of the mucosa obstructing nasal cavity). The reactions scored with 4 points or more in 30 
min time were considered as confirmed rhinitis reactions to the test agent, if the control 
challenge test with placebo did not produce reactions. The test agents were commercial 
allergen test agents, if such were available. Otherwise we used the patient’s own 
workplace agents or pure ingredients of them to the challenge tests.  
 
In study II with the inhalation challenge tests the concentrations of the challenge 
agents were adjusted to mimic the exposure situation in the workplace and to remain 
below the Finnish OELs, if existing, to avoid irritant reactions. Challenge agents were 
used either as such, mixed in lactose powder, or diluted if serious reactions were suspected 
based on medical history or SPT reactions. The inhalation challenge tests usually lasted 
30-45 min. depending on the agent and patient reaction, but were finished earlier in cases 





Compared with local nasal challenges with type 1 immediate reactions, the evaluation 
of pulmonary reactions requires a follow-up of at least 6 hours after the exposure, because 
the dual and late reactions appear frequently in lower airways. In our clinic, the subjects 
are admitted as inpatients for the tests and the examinations usually last for 1–2 weeks, 
while local nasal challenges are typically done in 2 days.  
Challenge test criteria: nasal secretion and placebo reactions 
In the study I, we compared the diagnostic criteria used in FIOH with nasal scoring 
(Hytönen and Sala, 1996) and the amount of nasal secretion of 0.2g. The nasal secretion 
dripping out of the nose was collected in 30 min time to a pre-weighted plastic mug, and 
in the end of the follow-up period, the secretion from anterior to nasal skin-mucosa 
junction was suctioned in the anterior rhinoscopy to a pre-weighted suction tip (with tip 
size 2 mm) with a collector, if needed. The total nasal secretion was weighted. In cases 
which the amount of secretion was scored normal (1) or dry (0), with no change of scoring 
points from rhinorrhea, the amount of secretion was valued in this analysis as zero. The 
number and percentage of provocation tests with positive reactions with the occupational 
agents and the control agents were evaluated. 
 
In the study II, provocation tests in occupational inhalation challenges concerning 
rhinitis were done according to the international guidelines of bronchial challenge tests 
(Moscato et al., 2003; Vandenplas et al., 2006), except that the patients were instructed to 
breathe through the nose and through the mouth on alternate breaths. In the case of 
commercial allergens, the Spira facial mask (Laerdal Medical, Stavanger, Norway) was 
used, covering both the nose and the mouth.  
Classification of the provocation test agents 
The challenge test agents were classified to organic and inorganic agents, with the type of 
the most-likely allergen or agent provoking the OR reaction. We analyzed the number of 
IgE-mediated and positive reactions in the provoked rhinitis reactions in each group of the 
provocation agents used.  
Questionnaires to measure health-related quality of life (III) 
The RAND-36 Item Health Survey 1.0 (RAND-36) (Hays et al., 1993) was chosen for the 
assessment of general HRQoL as it is known among the most common questionnaires 
available and it is well validated. The Rhinasthma questions were chosen for the 






For possible influence to HRQoL, we analyzed level of education, employment over 
the last 12 months, current rate of smoking, number of years of smoking, diagnosis of 
asthma made by a doctor and use of rhinitis medication during the last year.  
Statistics 
In the paper III, the differences of the means between the patients and the controls were 
tested using one-way nonparametric Kruskal-Wallis analysis of variance. The Mantel-
Haenzel chi-square test was used with chi-square tables. Correlations between the 
Rhinasthma and RAND-36 scores were analyzed using Spearman correlation coefficients. 
The differences between HRQoL of differently exposed groups of patients and controls 
were compared using Wilcoxon two-sample tests, and all occupational protein allergens 
causing OR were considered to constitute one group in the analyses.  
Wheat protein extraction, purification and skin prick tests (IV) 
Water-soluble wheat (Triticum aestivum, cultivar Tjalve) proteins were extracted from 
grounded grains in ammonium bicarbonate or ethanolamine with constant stirring for 4 
hours. After centrifugation supernatants were collected, filtered and frozen as aliquots. 
Protein assays were made. Ammonium bicarbonate extracts were used to analyze IgE 
reactivity of wheat water-soluble proteins by immunoblotting after 2-dimensional (2D) 
sodium-dodecyl-sulphate polyacrylamide gel electrophoresis (SDS-PAGE), and 
ethanolamine extracts were used for isolation of water-soluble proteins from wheat flour. 
 
Purification of proteins from ethanolamine extracts involved gel filtration and 
reversed-phase chromatography. The fractions containing certain proteins (identified by 
tandem-MS and shown to be allergenic by immunoblotting) were pooled, concentrated 
and further purified by another gel-filtration step. The final purification of different 
protein pools was performed by reversed-phase chromatography. 
Identification and characterization of wheat allergens  
Water soluble proteins from wheat ammonium bicarbonate extracts were separated by 
means of electrophoresis 2D SDS-PAGE and analyzed by immunoblotting to detect 
proteins that bind IgE in the sera of patients with baker's rhinitis and asthma. Purification 
of wheat allergens was monitored by 1-dimensional (1D) SDS-PAGE and 
immunoblotting. For molecular characterization of proteins, the molecular mass and 




1- and 2-dimensional sodium-dodecyl-sulphate polyacrylamide gel 
electrophoresis 
Protein samples were evaporated and reducing buffer was added for 1D SDS-PAGE. To 
perform 2D-SDS-PAGE, crude wheat extract was rehydrated and the mixture was 
absorbed into immobilized pH gradient strips. Isoelectric focusing was performed after 
which proteins were separated with 12 % SDS-PAGE according to the manufacturer's 
instructions (BioRad). After 2D SDS-PAGE, one of the parallel gels was stained and the 
other one was exposed to immunoblotting with sera from baker's rhinitis and asthma 
patients. 
Immunodetection for wheat allergens 
Immunoblotting was performed as described previously with modifications (Palosuo et 
al., 2001a). Briefly, proteins were transformed by electrophoresis (MiniTransBlot, 
BioRad) from SDS-PAGE gels onto polyvinylidene fluoride membranes. After that 
membranes were incubated with diluted patient's sera. Biotinylated goat anti-human-IgE 
was added, followed by streptavidin-conjugated alkaline phosphatase and the colour 
development solution. 
Tandem mass-spectrometry 
Protein spots were cut out from the gels, reduced and alkylated before in-gel digestion 
with modified sequencing grade porcine trypsin (Promega, Madison, Wisc). After removal 
of the supernatants, the remaining peptides in gel pieces were extracted twice. Combined 
peptide extracts were dried in a vacuum centrifuge. Each peptide mixture was analyzed by 
automated LC–MS/MS coupled to an electronspray ionisation quadrupole TOF MS. 
Reversed phase separation of peptides was carried out. Peptides were eluted from the 
column with a linear gradient. 
 
The obtained mass fragment spectra were searched in the non-redundant protein 
database compiled by the National Center for Biotechnology Information against all 
entries using in-house Mascot v.2.1 (Matrix Science Ltd., London, UK) with the following 
parameters: trypsin specificity; one missed cleavage; precursor ion mass accuracy of 0.2 
Da and 0.5 Da mass tolerance for fragment ions; fixed modification was 
carbamidomethylation of cysteine and oxidation of methionine, histidine and tryptophan 
were accepted as variable modification (Chamrad et al., 2004).  
Skin prick tests 
Skin prick tests (SPT)s were done according to the general guidelines (Mailing, 1993). 




specific serum IgE test, or both. Purified wheat allergen proteins (concentrations 5, 50 and 
500 g/ml) were used in SPTs. Skin wheals  3 mm were considered to show sensitization 
to a purified wheat allergen (Juntunen-Backman et al., 1995). Histamine 10 mg/ml was 
used as a positive control and commercial positive control, and PBS partly together with a 
Coca solution (sodium chloride 0.5%, phenol 0.4%, and sodium hydrogen carbonate 0.3% 





5.1 Provocation test studies (I-II) 
The nasal provocation tests (I) were positive in 39% of the occupational allergen 
provocations, whereas in 10% (19/193), placebo tests gave a positive provocation 
reaction. Forty-seven percent (78/165) of the patients were diagnosed as having OR. On 
average, three NPTs were performed on each patient, i.e. mainly one control and two 
allergen provocations. High-molecular-weight allergens caused most of the positive 
reactions in our patients. The flours (68% positive), and indoor plants and flowers (73%) 
were most likely positive in the provocation test, followed by animal allergens (37%). 
Wood dusts gave 50% positive NPT, mostly without IgE-sensitization. Atopic propensity 
was found in 90% of the patients reacting positively to dry wood dusts in our material. 
The NPTs performed towards molds were only seldom positive (18%), and only a 
minority of those patients had IgE towards molds (9%) or atopic propensity in skin prick 
tests (34%).  
 
Nasal secretion was measured or judged in most NPTs (84%), to test the parameter in 
the diagnosis of OR. In positive NPTs the nasal secretion varied between 0.1 and 11.3g, 
111/117 ≥ 0.2g. In all but one provocation secretion < 0.2 g (302/303) was regarded as no 
OR, so the measured secretion matched well with scoring. No generalized allergy 
reactions occurred in the provocation tests. 
 
Of the nasal provocation tests, 37% were control provocations and 10% (19/189) out 
of them were positive. Among the patients with positive control tests agent reactions, 
some elicited similar rhinitis reactions as the occupational agents. Among these cases, 
there were some patients suffering from nasal polyposis and patients who had challenge 
tests done with glycerol-containing agents. Mostly, the repetition of the nasal challenge 
test did clarify the situation, especially if temporary hyperactivities of the nose were 
withdrawn.  
 
In inhalation challenge tests (ICT)s (II) evaluated, an average of three challenges were 
performed on each patient. Rhinitis appeared in 13% (111/829) of the challenged patients, 
while asthmatic reactions appeared in 25% (211/829) of these patients. From the 
inhalation challenge tests 10% produced positive rhinitis reaction and 13% of the tests 
positive asthma reaction. Organic agents were the most frequent causes of OR in our 
patients and, the causes of them were quite similar to the NPT.  
 
Inorganic causes causing rhinitis reactions in the inhalation challenge tests are shown 




Table 2: Inorganic agents causing rhinitis in the inhalation challenge tests 




Acid anhydrides  14 hardeners in epoxy resin systems, 
welding of painted metal 
Formaldehyde and 
glutaraldehyde 
11 chemistry reagents, particleboards, 
cloths, fixatives, machining fluid 
(main suspected agent) 
Persulphates, thioglycolates 
and paraphenylenediamine 
13 hairdresser's chemicals 
Methacrylates and acrylates 7 tooth fillings, adhesive glues and 
hair sprays 
Di-isocyanates 3 paint hardeners and wood coatings 
Welding fumes  2 welding 
Chloramine-T 2 disinfectant in cleaning work 
Colophony fumes 1 soldering 
PVC fumes 1 PVC heating 
Epoxy 1 glue 
Aziridine (ethylene imine) 2 leather finishing work 
 
Inhalation challenge tests with a placebo agent produced rhinitis reactions in 2% of the 
challenges in our study, and 10% of the occupational challenges triggered rhinitis 
reactions that were considered as OR. In the NPT, we have previously described a higher 
proportion of rhinitis reactions, both from occupational (39%) and placebo challenges 
(10%). All nasal challenges were done without any serious reactions. No anaphylactic 
reactions have appeared in our institute in the ICTs.  
5.2 Health-related quality of life study (III) 
Sixty-two percent (62%) of the OR patients, and forty-four percent (42%) of the controls 
completed the questionnaire. The occupational allergens in the respondents' and non-
respondents' groups were similar, but the respondents were on average 3.5 years older than 
the non-responders (45 and 49 years, p<0.0001), and women answered more often than 
men did (69% and 55%, p<0.0001).  
 
During the questionnaire, 22% of the OR patients were no longer exposed to the 
occupational agent that had caused their OR. Fifty-eight percent of the patients estimated 
that their exposure had decreased, and 20% felt having similar or increased occupational 





The OR patients suffered from perennial rhinitis symptoms significantly more often 
(26%) than the age and sex matched control population (18%), while the controls reported 
more seasonal rhinitis, compared to the patients (41% versus 20%, p=0.0002). A total of 
20% of the patients in our study used rhinitis medications regularly, 53% periodically or 
temporarily, and 27% not at all. Only 10% of the controls who answered used regular 
rhinitis medication, 47% periodically or temporarily, and 43% not at all (p=0.001). The 
controls and patients results in the subgroups are shown in Table 3 below.  
 
Table 3: Frequency of using rhinitis medication among patients with occupational rhinitis 
compared to controls with or without AR (complementary findings by Airaksinen et al, 
unpublished results) 




 % of the 
answers 
Patients (with no 
exposure- low exposure- 
most exposed group) 
% of the answers  
Controls 
with AR  
% of the 
answers 
Regularly 2 8-15-52 32 
Periodically or temporarily 45 52-60-34 53 
Not at all 53 40-25-14 15 
 
The types of medication were mainly corticosteroids and antihistamines (Table 4) in 
our responders, but the response to this question was low (23-42% of all patients) and 
therefore these results need to be considered as suggestive only.  
Table 4: Types of rhinitis medications used among patients with occupational rhinitis years after 
their diagnosis (complementary findings by Airaksinen et al, unpublished results) 
The work attendance of the patients and the controls did not differ. A total of 17% of 
our patients had been re-educated because of OR. Out of the re-educated patients, 9% 
reported increase, 33% decrease, and 58% no changes in livelihood due to OR.  
 
As we grouped the patients according to their current occupational allergen exposure 
the respiratory HRQoL of the patients no longer exposed to occupational allergens did not 
differ from the healthy controls. Occupational allergen exposure that had remained similar 
Rhinitis 
medications used 






















% of the 
answers 
Antihistamines 23 21 22 11 8 15 
Corticosteroid-
sprays 
39 8 20 6 7 20 
Leukotriene 
antagonists 





or increased since the time of OR diagnosis, lowered the patients' respiratory HRQoL to 
the same extent as did the diagnosed AR among the controls.  
 
The non-exposed patients had no differences to the healthy controls except in one 
RAND-36 score. The bodily pain score indicated an even higher HRQoL among the non-
exposed OR patients than among the healthy controls. Only the general health score was 
statistically lower among the exposed OR patients compared to non-occupational AR.  
 
Determinants of HRQoL in our study found were reduced livelihood due to OR, 
frequency of rhinitis medication usage, and asthma which was related to deteriorated 
HRQoL both in Rhinasthma and RAND-36. Education did not influence any Rhinasthma 
scores, but did affect the RAND-36 general health score (p<0.01), physical functioning 
score (p<0.0001) and physical role scores (p<0.05). Age did not affect the Rhinasthma 
scores, but did decrease five out of eight RAND-36 scores. The type of occupational 
allergen did not have influence on the results of Rhinasthma or RAND-36.  
5.3 Occupational respiratory wheat allergy (IV) 
Water-soluble extract of wheat grains is protein-rich and Western blotting with sera of 
baker's rhinitis and asthma patients indicated that many of these proteins among our 
patients bind IgE, i.e., are allergens. However, IgE-binding responses of individual 
patients to these proteins varied. Tandem MS analysis of IgE-binding protein bands 
suggested that especially alpha-amylase inhibitor -AI (MW = 12-17 kDa), lipid transfer 
proteins LTP 1 (MW = 12 kDa) and nsLTP2G (MW = 7 kDa), thaumatin like protein 
(TLP) (MW = 23 kDa), 1-Cys-peroxiredoxin (PER1) (MW = 24 kDa), glutathione S-
transferase (GST) (MW = 25 kDa), 27K protein, xylanase inhibitor protein 1 (MW = 34 
kDa) and peroxidase I (MW = 39 kDa), are important allergens among our baker's rhinitis 
and baker's asthma patients.  
 
Two gel filtration steps and reverse-phase chromatography were used to separate IgE 
reactive water-soluble wheat proteins from each other. We focussed to purify LTP, -AI, 
PI and TLP. In SPTs, all our wheat respiratory allergy patients had positive SPT to a total 
wheat flour preparation and to the pool of water-soluble wheat proteins. Dose-dependent 
SPT responses to purified water-soluble wheat allergens were found and 75% of our 
patients (15/20) recognized at least one tested wheat allergen in SPT, on average 2/5 (from 
0/5 to 5/5). Sixty percent, 60% of the patients recognized -amylase inhibitor as an 
allergen, 45% recognized TLP and PI, and 30% recognized LTP as an allergen. All ten 






6.1 Provocation test studies (I, II): aetiology, diagnostics and 
classification  
 
Nearly half of the patients with upper respiratory related rhinitis symptoms did receive a 
diagnosis of occupational disease in NPTs (47% of the patients had positive provocation 
test), but in the inhalation challenge tests it was quite rare finding (only 13% of the 
patients had a rhinitis positive challenge test). The patients who did not receive OR 
diagnosis, were likely to have unspecific hyperreactivity of the nose, work-exacerbated 
rhinitis, mild rhinitis reactions that did not reach the diagnostic level, or some other form 
of concurrent rhinitis or upper airway irritations.  
 
The patient material in this thesis was highly selected. According to the medical 
history, immunological tests, clinical examination and related studies, the otolaryngologist 
selected 11% of the outpatient consultation patients with work-related rhinitis symptoms 
for nasal provocation test studies. To the inhalation challenge test came 21% of the 
patients visiting FIOH otolaryngologist.  Work-related rhinitis and simultaneous bronchial 
work-related symptoms were studied with otolaryngologist follow-ups in these inhalation 
challenge tests. The patients of this thesis, studied with provocation tests (I, II), had 
increased amount of atopy (in study I 47% and study II 37%) compared to general 
population (34% during the time of the studies). The increased amount of atopy among the 
patients studied may partly explain the quite high percentage of nasal hyperreactivity 
reactions found in the placebo tests in the study I (10%) compared to the study II (2%). 
The causative agents suspected, patient materials and the provocation tests were different 
in studies I and II, also affecting to the results.   
 
The nasal provocation test scoring criteria used in FIOH for NPT positivity evaluation 
was compared to nasal secretion amount of 0.2 g. We derived it from one unilateral NPT 
method for nasal provocation test evaluation (Pirilä and Nuutinen 1998) by multiplication 
of cumulative nasal secretion of 30 min time by two to 0.2 g. Our patient material was 
retrospective in nature, heterogeneous and there were numerous causative agents and 
many allergen and occupational materials in it. These facts result in wide normal 
variations for the test results. The study of Pirilä and Nuutinen was a prospective work 
with one allergen, homogenous patient materials with selected controls and several 
methods of evaluation of NPT. Taking these limitations into account, and comparing the 
results, most of the scoring positive NPT results of FIOH had positive nasal secretion 
criteria ≥ 0.2 g (111/117 provocations), and all cases with positive NPT had at least 0.1 g 
secretion amount. The result favours that the two different methods of nasal provocation 




nasal secretion amount is useful, easily used and good criteria in the nasal provocation 
tests and in comparisons of various challenge test method results. 
 
The nasal and inhalation challenge test methods differ in several ways, but we used the 
same rhinitis criteria in their evaluations. In nasal challenges, most of the tested agents are 
IgE-mediated allergens, and the typical allergic rhinitis reactions are usually quite strong 
and easy to recognize, if the allergens used and their concentrations are adequate. In 
specific NPT, the local concentration of the allergen used becomes higher than during the 
inhalation challenge test, without the fear of serious reactions. As the NPT is searching for 
IgE-mediated allergy, the results of sensitization can be used mostly to the selection of the 
patients to the provocation tests. In ICT the non-IgE mediated reactions are more 
common, and the non-IgE-mediated reactions are not so well understood, or characterized, 
and therefore the patient selection to the challenge tests is more challenging. Inhalation 
challenges with LMW (generally inorganic agents) have been reported to produce less 
intensive rhinitis than the ones with HMW (generally organic protein challenges) (Malo et 
al., 1997), although the prevalence of the symptoms do not differ in HMW and LMW 
agents. This may relate to a fact that HMW agents generally exist as dry or liquid aerosol, 
whereas LMW agents are more generally vapours. The aerosols may more readily be 
deposited in the upper airways and cause symptoms there.  
 
NPT was safe and well-tolerated in our patients. No serious reactions have occurred in 
these provocation test series. In the ICTs it has been estimated that chamber challenge 
reactions may cause asthmatic symptoms to exacerbate for a few days after the challenge 
with ≤ 5% of asthmatic patients, (Vandenplas et al., 2006). Most asthmatic reactions were 
resolved with inhalation drugs; only a few reactions have been intravenously treated in our 
series. In the future the closed-circuit aerosol and vapour exposure chamber system can 
tailor concentrations of dusts and aerosols, and can further reduce the risk of eliciting > 
30% FEV1 falls more than 10%, compared to "the realistic" methodology used in the ICTs 
analyzed this thesis (Cloutier et al., 1989; Malo et al., 2004).  
 
In the challenge tests studied, IgE mediated organic allergens gave more often positive 
results. In both nasal provocation tests and inhalation challenge tests studied, the mold 
challenge reactions were found to have low rate of positive challenge test findings both in 
nasal and inhalation challenge tests. Our results showed that the majority of the nasal 
symptoms in moisture-damaged buildings are non-IgE-mediated, as has been previously 
suggested (Ruoppi et al., 2003). Several indoor air factors, like volatile organic 
compounds (VOC)s have been suggested to be involved in the aeroirritant effect found in 
the exposures to fungi (Hope and Simon, 2007), as well as bacterial endotoxins (Pestka, et 
al. 2008), air CO2 concentration, poor ventilation (Hagerhed-Engman et al., 2009), 
common indoor contaminants, air humidity, movement and temperature factors (United 
States Department of Labor, 2008) and psychosocial and personal factors (Ebbehoj et al., 
2005). However the mechanisms associated to moisture damages have been also stated to 
be partly unknown (Bornehag et al., 2001). After these, our and other evaluations of the 
mould provocations in FIOH, the practice of mold provocations has been changed to be 





Only a minor part of respiratory complaints among woodworkers were connected to 
specific sensitization in our material. In some cases, there may be nasal crusting and 
dryness, symptoms other than included in the definition of rhinitis, found relevant to the 
nasal symptoms at work (Hellgren et al., 2003). In our patients with suspicion of 
occupational rhinitis and positive nasal challenge test to wood dusts, concomitant 
sensitization to ubiquitous aero-allergens was found in 90%, and concomitant sensitization 
has also previously been found to be more common among persons with airway diseases 
from wood dusts compared to the general population (Skovsted et al., 2003). As a result, 
we suggest that unspecific mucosal hypersensitivity and mechanical and perhaps some 
hydroscopic irritation of the nasal mucosa are likely causes to some, and to be a major 
modifier to most of the rhinitis symptoms of these patients in NPT. In sawmills, where 
fresh wood is handled, also endotoxines, airborne fungi, bacteria and (1.3)-glucan may 
take part in the airway irritation (Rusca et al., 2008) and symptoms. Yet, the mechanisms 
behind the irritation caused by wood dusts have been so far only partly resolved. 
 
A recent EAACI position on OR and an earlier paper on provocation tests with 
allergens give a lot of guidelines to the occupational nasal challenges (Melillo et al., 1997; 
Moscato et al., 2009). In our study we analyzed the placebo reactions as well as the 
occupational agent reactions. The results of the placebo reactions have been mainly 
lacking from the provocation test reports done before. There are some reports describing 
the effect of several repeated challenge tests enhancing the nasal responsiveness (priming 
effect) (Ciprandi et al., 1998), but the baseline nasal reactivity of the patients or unspecific 
nasal hyperreactivity like in relation to nasal comorbidities are seldom documented. 
Although there are no studies, to our knowledge, in relation to the placebo test criteria, the 
practice of FIOH has been to repeat the challenge test if the control test was positive and 
treat all temporary causes of hyperreactivity before the retest. If the hyperreactivity was 
still present during the control test, the occupational challenge test reaction must be 
markedly larger than the placebo test reaction, to support or confirm the specific 
occupational rhinitis. In nasal provocation tests studied, glycerol and phenol containing 
placebo agents (skin prick test placebo agents used) induced more positive placebo 
reactions than water-based agents in our results. Therefore, it was suggested that water-
based provocation agents only should be used. This is supported by earlier findings 
(Haahtela and Lahdensuo, 1979).  
6.2 Occupational rhinitis and health-related quality of life (III) 
The Health-related quality of life (HRQoL) among OR patients had been little studied so 
far. In the questionnaire study of the thesis it was found that continuing occupational 
allergen exposure decreased HRQoL among the occupational allergic rhinitis patients and 
that the HRQoL of patients without occupational allergen exposure were mainly similar 
than that of the healthy controls. The results highlight the importance of the reduction and 




the determinant role of the occupational allergen to HRQoL. The result is well in line with 
the study where greenhouse workers' allergic rhinitis-related HRQoL was studied, and the 
most significant occupational allergen in their work (bell pepper pollen) and common 
perennial allergies were compared (Groenewoud et al., 2006). In that study, bell pepper 
pollen allergy had a higher relative impact than the environmental allergies on the Rhinitis 
Quality of life Questionnaire (RQLQ).  
 
Allergy medication and its use are known to alleviate rhinitis symptoms and improve 
the HRQoL of rhinitis patients (Tripathi and Patterson, 2001). Antihistamines and nasal 
steroids are well known as the most effective options for treating AR (Tripathi and 
Patterson, 2001), although the situation may change. Accordingly, the antihistamines and 
nasal steroids were the main rhinitis medications used among the patients. Frequency of 
medication usage was also related to the patients' estimation of their current exposure 
level. Nevertheless, as the regular use of rhinitis medications was related to lower 
HRQoL, it seems that they only improve OR, not cure it. Our result strongly points out 
that in order to improve the quality of life of OR patients, medication only is not a 
sufficient treatment for OR; reduction or cessation of exposure to the sensitizing agent at 
the workplace is needed as the main intervention.  
 
The bodily pain score showed the biggest difference in general HRQoL scores. The 
non-exposed OR patients had statistically less pain compared to the healthy controls. The 
patients who had not been able to reduce their exposure level since OR diagnosis 
experienced most bodily pain. Previously in seasonal AR, the HRQoL measured with SF-
36 during and outside the pollen season was significantly changed in factors of physical 
functioning, physical role limitation and bodily pain (Majani et al., 2001). In some other 
reports, low back pain, and depression or neurosis are significantly linked with allergic 
pollinosis (Hurwitz and Morgenstern, 1999; Hashimoto et al., 2007). In addition, 
headache is also 1.5 times more common in persons with AR than among non-allergics 
(Aamodt et al., 2007). In fact, headache has been found to coexist in 41% of perennial AR 
patients in a symptom survey and less so in seasonal AR (Scadding et al., 2000). In 
addition, it may be, that the patients who were not able to reduce their exposure may have 
more comorbidities, explaining the pain results. In our study the non-exposed OR patients 
had statistically less pain compared to the healthy controls. This may be explained, on the 
opposite, by better opportunities to improve the situation, such as change exposure level, 
lack of allergic symptoms or any comorbidity. The detailed differences in the pain 
experiences were not specifically questioned in this work, though.  
 
Among occupational latex allergic patients, the complete removal of the exposure has 
been reported to be statistically related to reduced income, compared to those who had 
reduced exposure (Vandenplas et al., 2002). Re-education or job change can also have 
marked professional career consequences: in some reports, it is associated with frequent 
persistent work disruption. In contrast to this, in our results, the employment rate was 
similar among the patients and the controls. The occupational rhinitis had caused re-
education to 17% of the OR patients though. Out of the re-educated patients, 9% reported 




education due to occupational diseases is discretionarily compensated by mandatory 
insurance, if the allergen load cannot reasonably be avoided or reduced in the workplace.  
 
The risk of asthma among OR patients is higher than among the general population 
(Karjalainen et al., 2003). Earlier studies with e.g. RAND-36, state that the more diseases 
the patient has, the lower their HRQoL is (Aalto et al., 1999). In our study, asthma was 
related to lower HRQoL in both Rhinasthma and RAND-36, which is in line with previous 
works. 
 
In the study III, the response rate was quite typical for a questionnaire study. We might 
have increased the response rate by directly contacting the patients, through calling, or 
selecting the patient material to include only native Finnish or Swedish persons, or by 
excluding the eldest group of patients. Anyhow, according to the literature, the 
nonresponders of respiratory symptom questionnaires may influence the prevalence rates 
of respiratory symptoms (like with 3-7% underestimation of symptoms, and up to 16% 
difference in smoking) (Kotaniemi et al., 2001). As in our study the rate of reported 
asthma was in similar magnitude to the previous reports and smoking did not influence the 
HRQoL results according to the statistical analyses, we consider that the nonresponders 
influence to our results was not likely to be significant. 
 
6.3 Occupational wheat allergens  
Rhinitis and asthma in bakers and bakery workers is often referred to as baker's rhinitis 
and baker's asthma. Flours are the main causative agents of these diseases, and wheat is 
the leading flour used in the western world. Recognition of relevant allergens is important 
for the development of more specific in vitro diagnostics, for the standardization of 
allergen preparations used and for the possible development of desensitization treatment 
of baker's respiratory allergy. 
 
Strong cross-reactivity exists between allergens from different cereals, which was also 
seen in our study. The number of IgE-reactive wheat proteins was found to be high in the 
patient's sera. Earlier, as many as 40 different antigens have been found and cross-
reactivities between other flours and common grass pollen (Blands et al., 1976). 
Accordingly, in our results some of the patient sera recognized only a few proteins 
whereas others reacted to several protein spots in immunoblot.  
 
The work was one of the few comparing the clinical importance of various respiratory 
wheat allergens to the occupationally wheat allergic patients. The occupational wheat 
allergens are mainly different from the non-occupational diseases oral wheat 
hypersensitivity and wheat-dependent exercise-induced anaphylaxis, in which gliadins are 
the major allergen group (Varjonen et al., 2000; Palosuo et al., 2001; Battais et al., 2003). 




soluble wheat allergens. Fifteen percent of our patients showed some positivity towards 
gliadin in SPT, but other tested allergens had stronger reactions at the same time. We 
found this to be in line with the presumption that these proteins are stronger allergens for 
wheat allergy from oral ingestion rather than respiratory exposure (Palosuo et al., 1999; 
Palosuo et al., 2001b). 
 
Our study was the first showing that thaumatin-like protein (TLP), to which 45% of 
our patients recognized as an allergen, is an allergen in baker's respiratory allergy. TLP 
belongs to plant defence proteins which are important allergens of several fruits such as 
apples and cherries (Breiteneder, 2004) while in grains they prevent fungal diseases. 
 
The result showed 30% of reactivity to reactivity to purified lipid transfer protein 2G 
(LTP2G), which had not previously been found as allergen. Another LTP, from water 
extracts of wheat LTP1 (in allergen nomenclature Tri a14), had previously found as one 
baker's allergen (Palacin et al., 2007). Our results suggest that several LTP proteins can 
induce allergy among bakers.  
 
Peroxidase I has previously been found to be a wheat allergen in patients with baker's 
asthma (Sanchez-Monge et al., 1997; Baur and Posch, 1998; Yamashita et al., 2002). Our 
results confirmed the earlier findings and concluded that 45% of our patients were 
sensitized to this allergen.  
 
In an earlier study with a recombinant protein of alpha amylase inhibitor -AI, 65% of 
patients with baker's asthma were sensitized to this protein (Weichel et al., 2006). This 
group of proteins were confirmed to be baker's major allergens also in our study, because 
60% of our patients had positive SPT to the alpha-amylase inhibitor proteins.  
 
In addition, our study identified other wheat allergen proteins, whose importance in 
baker's rhinitis waits for further studies: xylanase inhibitor protein, 1-Cys-peroxiredoxin, 




6.4 Some unmet needs in OR 
This thesis and a recent consensus paper (Moscato et al., 2009) have raised a few unmet 
needs in the OR field that can be addressed in the future:  
 
 There are no HRQoL studies with all causative agents and longitudinal follow up 
 There are no cost-evaluations of the rehabilitation of OR  
 The allergen extracts used, methods of measuring non-specific nasal 
hyperreactivity, nasal inflammation and provocation tests need standardization  
 There is a need for an internationally validated questionnaire to identify OR in 
epidemiologic work and clinical practice  
 The diagnosis number of irritation rhinitis is missing in ICD-10 
 There is currently no data on nasal NO changes in challenge tests with various 
chemicals and irritants and versus allergens 
 There is a need for prospective immunotherapy studies with occupational allergens  
 There is a need for studies assessing parameters influencing the prognosis of OR, 
and effects of interventions on the development of OA 
 There is a need for consensus criteria for grading impairment/ disability resulting 




7. Summary and conclusions 
I & II  
 
Nearly half of the patients (47%) with upper respiratory related rhinitis symptoms selected 
to the nasal challenge tests did receive positive reactions suggesting occupational rhinitis 
in NPTs, but among the patients studied with the inhalation challenge tests positive 
rhinitis reactions was rarer (13%). The causes of OR were mainly AR. 
 
The specific nasal and inhalation challenge tests were found to be valuable tools when 
there is uncertainty whether the patient's exposure should be discontinued or the patient 
should change his or her job. The provocation test mostly does prove or concludes the 
suspicion of occupational origin of the rhinitis when the allergens are well characterized, 
and there is no other comorbidity in the nasal mucosa. Both nasal and inhalation challenge 
test methods were found as safe procedures in our evaluation. Mostly the repetition of the 
nasal challenge test could clarify the situation, especially if temporary hyperreactivities of 
the nose are withdrawn. Only markedly stronger provocation test reactions with the 
occupational agent compared to the control agent reactions can be considered to confirm 
the suspected OR. That can be interpreted analogous to one SPT criteria where the skin 
wheal caused by an allergen needs to be markedly larger than the negative control to be 
considered as a positive reaction. 
 
The nasal provocation test scoring criteria used in FIOH was compared to nasal 
secretion amount of 0.2g. The scoring criteria used and nasal secretion criteria for nasal 
provocation tests gave quite similar results. It is in favour that nasal secretion amount is 
useful, easily used and reliable criteria in the nasal provocation tests.  
 
Provocation tests used were found safe and well-tolerated in our patients. No serious 
reactions have occurred in these provocation test series. In addition, simultaneous 
evaluation of both upper and lower airways is cost-effective compared to separate nasal 




Twenty-two percent of the occupational rhinitis (OR) patients were no longer exposed to 
the occupational agent that had caused their OR on average 10 years after their diagnosis. 
Seventy-eight percent of the patients had continuing allergen exposure to the agent that 
had caused their OR. Continuing occupational allergen exposure was related to decreased 
HRQoL among the patients. The HRQoL of patients without occupational allergen 
exposure was mainly similar than that of the healthy controls. In addition regular use of 
rhinitis medications was related to continuing exposure and to lower HRQoL among OR 
patients. These results strongly point out that in order to improve the quality of life of OR 
patients, medication only is not a sufficient treatment for OR; reduction or cessation of 





The long-term employment rate was similar among the Finnish OR patients and the 
controls. Seventeen percent of the OR patients were re-educated because of occupational 
rhinitis. Out of the re-educated patients, 9% reported increase and 33% decrease in 
livelihood due to OR. 
 
 IV  
 
It was confirmed that patients with baker's rhinitis and asthma recognize in vivo several 
different water/salt -soluble proteins from wheat grains. Several recognized allergens, 
alpha-amylase inhibitors, peroxidase I, thaumatin-like protein, lipid transfer protein 2G 
and wheat crude gliadin were tested in SPT in baker's respiratory allergy patients. Alpha-
amylase inhibitors, lipid transfer protein 2G, thaumatin -like protein, and peroxidase I 
were found to be relevant allergens in Finnish patients with occupational wheat allergy. Of 
these allergens, thaumatin-like protein and lipid transfer protein 2G were found as new 
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Appendix 1: Rhinasthma questionnaire used (in Finnish)  
Minkä verran seuraavat hengitystieoireisiin liittyvät asiat ovat vaivanneet teitä viimeisten 
12 kuukauden aikana? (Ympyröikää sopiva numero)  
   
 1                                            5 
 (ei lainkaan)          (erittäin paljon) 
1. Kurkun selvittäminen  1 2 3 4 5 
2. Tarve käyttää lääkkeitä 1 2 3 4 5 
3. Tarve käyttää rahaa (lääkkeet, lääkärikäynnit) 1 2 3 4 5 
4. Puristava tunne rintakehässä 1 2 3 4 5 
5. Hengenahdistus 1 2 3 4 5 
6. Silmien kutina 1 2 3 4 5 
7. Tarve pitää lääkkeitä mukanaan 1 2 3 4 5 
8. Nenän valuminen 1 2 3 4 5 
9. Yöheräilyt 1 2 3 4 5 
10. Aivastuttaminen  1 2 3 4 5 
11. Rajoitukset vapaa-ajan toimiin  1 2 3 4 5 
12. Vaikeus nukahtaa  1 2 3 4 5 
13. Liikuntasuoritusten heikkeneminen 1 2 3 4 5 
14. Tarve nenäliinojen mukana pitämiseen 1 2 3 4 5 
15. Rajoitukset päivittäiseen elämään 1 2 3 4 5 
16. Keskittymisvaikeudet 1 2 3 4 5 
17. Hengästyminen 1 2 3 4 5 
18. Tarve välttää tiettyjä ympäristöjä 1 2 3 4 5 
19. Nenän tukkoisuus 1 2 3 4 5 
20. Hajuaistin heikkeneminen 1 2 3 4 5 
21. Huoli ettei olisi lääkettä 1 2 3 4 5 
22. Nenän kutina 1 2 3 4 5 
24. Tarve käydä lääkärissä  1 2 3 4 5 
23. Silmien punoitus 1 2 3 4 5 
25. Yskä 1 2 3 4 5 
26. Rajoitukset tehdä mitä haluaisi 1 2 3 4 5 
27. Lääkkeiden sivuvaikutukset 1 2 3 4 5 
28. Silmien arkuus 1 2 3 4 5 
29. Hengityksen vinkuminen 1 2 3 4 5 





          Rhinasthma questionnaire used (in Swedish)  
 
I vilken mån har ni besvärats av följande faktorer i samband med symptom i luftvägarna under de 
sista tolv månaderna? (Inringa det rätta svaret)  
 
                                                                                  skala:   1...                             5  
                                                                                    (inte alls)                                     (i hög grad) 
1. Behov att harkla strupen 1 2 3 4 5 
2. Behov att använda mediciner 1 2 3 4 5 
3. Behov att använda pengar (mediciner, läkare) 1 2 3 4 5 
4. Tryckande känsla i bröstkorgen 1 2 3 4 5 
5. Kliande ögon 1 2 3 4 5 
6. Andnöd 1 2 3 4 5 
7. Behov att ha mediciner till hands 1 2 3 4 5 
8. Rinnande näsa 1 2 3 4 5 
9. Vaknande om natten 1 2 3 4 5 
10. Behov att nysa 1 2 3 4 5 
11. Begränsningar som gäller fritidsaktiviteter  1 2 3 4 5 
12. Försämrad idrottsprestation 1 2 3 4 5 
13. Svårigheter att somna 1 2 3 4 5 
14. Behov att ha näsdukar till hands 1 2 3 4 5 
15. Begränsningar i det vardagliga livet 1 2 3 4 5 
16. Sänkt koncentrationsförmåga 1 2 3 4 5 
17. Andfåddhet  1 2 3 4 5 
18. Behov att undvika vissa omgivningar 1 2 3 4 5 
19. Tilltäppt näsa 1 2 3 4 5 
20. Försämrat luktsinne 1 2 3 4 5 
21. Rädsla att vara utan medicin 1 2 3 4 5 
22. Kliande näsa 1 2 3 4 5 
23. Röda ögon 1 2 3 4 5 
24. Behov att uppsöka läkare 1 2 3 4 5 
25. Hosta 1 2 3 4 5 
26. Begränsad möjlighet att göra vad man vill 1 2 3 4 5 
27. Biverkningar av medicin 1 2 3 4 5 
28. Känsliga ögon 1 2 3 4 5 
29. Pipande andetag 1 2 3 4 5 





Appendix 2: RAND-36 1.0 questionnaire (in Finnish) 
1. Onko terveytenne yleisesti ottaen ... (ympyröikää yksi numero) 
 1 erinomainen 
 2 varsin hyvä 
 3 hyvä 
 4 tyydyttävä 
 5 huono 
 
2. Jos vertaatte nykyistä terveydentilaanne vuoden takaiseen, onko terveytenne yleisesti ottaen ...  
(ympyröikää yksi numero) 
 1 tällä hetkellä paljon parempi kuin vuosi sitten 
 2 tällä hetkellä jonkin verran parempi kuin vuosi sitten 
 3 suunnilleen samanlainen 
 4 tällä hetkellä jonkin verran huonompi kuin vuosi sitten 
 5 tällä hetkellä paljon huonompi kuin vuosi sitten 
 
Seuraavassa luetellaan erilaisia päivittäisiä toimintoja. Rajoittaako terveydentilannenykyisin 
suoriutumistanne seuraavista päivittäisistä toiminnoista? Jos rajoittaa, kuinka paljon? (ympyröikää 
yksi numero joka riviltä)  kyllä, kyllä,  ei rajoita 
   rajoittaa  rajoittaa  lainkaan 
   paljon  hiukan 
3. huomattavia ponnistuksia vaativat toiminnat 
(esimerkiksi juokseminen, raskaiden tavaroiden 
nostelu, rasittava urheilu) ....................................... 1 ....................  2 ....................... 3 
4. kohtuullisia ponnistuksia vaativat toiminnat, 
kuten pöydän siirtäminen, imurointi, keilailu......... 1 ....................  2 .......................  3 
5. ruokakassien nostaminen tai kantaminen............  1 ....................  2 .......................  3 
6. nouseminen portaita useita kerroksia................. 1 ....................  2 .......................  3 
7. nouseminen portaita yhden kerroksen ............... 1 ....................  2 .......................  3 
8. vartalon taivuttaminen, 
polvistuminen, kumartuminen .............................. 1 .................... 2 .......................  3 
9. noin kahden kilometrin matkan kävely.............. 1 ....................  2 .......................  3 
10. noin puolen kilometrin matkan kävely............ 1 ....................  2 .......................  3 
11. noin 100 metrin matkan kävely........................ 1 ....................  2 .......................  3 
12. kylpeminen tai pukeutumine............................ 1 ....................  2 .......................  3 
 
Onko teillä viimeisen 4 viikon aikana ollut RUUMIILLISEN TERVEYDENTILANNE TAKIA alla 
mainittuja ongelmia työssänne tai muissa tavanomaisissa päivittäisissä tehtävissänne? (ympyröikää yksi 
numero joka riviltä)    Kyllä  Ei 
13. Vähensitte työhön tai muihin tehtäviin käyttämäänne aikaa..................................... 1 ................. 2 
14. Saitte aikaiseksi vähemmän kuin halusitte................................................................ 1 ................. 2 
15. Terveydentilanne asetti teille rajoituksia joissakin 
työ- tai muissa tehtävissä ............................................................................................... 1 .................. 2 
16. Töistänne tai tehtävistänne suoriutuminen tuotti vaikeuksia  
(olette joutunut esim. ponnistelemaan tavallista enemmän)............................................ 1 .................  2 
 
Onko teillä viimeisen 4 viikon aikana ollut TUNNE-ELÄMÄÄN LIITTYVIEN vaikeuksien (esim. 
masentuneisuus tai ahdistuneisuus) takia alla mainittuja ongelmia työssänne tai muissa 
tavanomaisissa päivittäisissä tehtävissänne? 
(ympyröikää yksi numero joka riviltä)   Kyllä Ei 
17. Vähensitte työhön tai muihin tehtäviin käyttämäänne aikaa .................................. 1 ................. 2 
18. Saitte aikaiseksi vähemmän kuin halusitte .............................................................. 1 ................. 2 
19. Ette suorittanut töitänne tai muita tehtäviänne yhtä 
huolellisesti kuin tavallisesti .......................................................................................... 1 .................. 2 
 
20. MISSÄ MÄÄRIN ruumiillinen terveydentilanne tai tunne-elämän vaikeudet ovat viimeisen 4 viikon 
aikana häirinneet tavanomaista (sosiaalista) toimintaanne perheen, ystävien, naapureiden tai muiden ihmisten 
parissa? (ympyröikää yksi numero )  
 1 ei lainkaan 
 2 hieman 
 3 kohtalaisesti 
 4 melko paljon 





21. Kuinka voimakkaita ruumiillisia kipuja teillä on ollut viimeisen 4 viikon aikana? (ympyröikää yksi 
numero) 1 ei lainkaan 
 2 hyvin lieviä 
 3 lieviä 
 4 kohtalaisia 
 5 voimakkaita 
 6 erittäin voimakkaita 
 
22. Kuinka paljon kipu on häirinnyt tavanomaista työtänne (kotona tai kodin ulkopuolella) viimeisen 
4 viikon aikana? (ympyröikää yksi numero) 
 1 ei lainkaan 
 2 hieman 
 3 kohtalaisesti 
 4 melko paljon 
 5 erittäin paljon 
 
Seuraavat kysymykset koskevat sitä, miltä teistä on tuntunut viimeisen 4 viikon aikana. Merkitkää 
kunkin kysymyksen kohdalla se numero, joka parhaiten kuvaa tuntemuksianne. (ympyröikää yksi numero 
joka riviltä). 
 Kuinka suuren osan ajasta olette viimeisen 4 viikon aikana ... 
   koko            suurim-      huomat-    jonkin         vähän        en 
   ajan             man            tavan         aikaa           aikaa        lainkaan  
                    osan          osan  
                                          aikaa           aikaa 
23. tuntenut olevanne täynnä elinvoimaa ........ 1 ............... 2 ............... 3 .............. 4 ............... 5 ............. 6 
24. ollut hyvin hermostunut .............................. 1 ............... 2 ............... 3 .............. 4 ............... 5 ............. 6 
25. tuntenut mielialanne niin matalaksi, 
ettei mikään ole voinut teitä piristää ................ 1 ............... 2 ............... 3 .............. 4 ............... 5 ............. 6 
26. tuntenut itsenne tyyneksi ja rauhalliseksi . 1 ............... 2 ............... 3 .............. 4 ............... 5 ............. 6 
27. ollut täynnä tarmoa .................................... 1 ............... 2 ............... 3 .............. 4 ............... 5 ............. 6 
28. tuntenut itsenne alakuloiseksi ja apeaksi.... 1 ............... 2 ............... 3 .............. 4 ............... 5 ............. 6 
29. tuntenut itsenne “loppuunkuluneeksi”…… 1 ............... 2 ............... 3 .............. 4 ............... 5 ............. 6 
30. ollut onnellinen ............................................... 1 ............... 2 ............... 3 .............. 4 ............... 5 ............. 6 
31. tuntenut itsenne väsyneeksi........................... 1 ............... 2 ............... 3 .............. 4 ............... 5 ............. 6 
 
32. Kuinka suuren osan ajasta ruumiillinen terveydentilanne tai tunne-elämän vaikeudet ovat 
viimeisen 4 viikon aikana häirinneet tavanomaista sosiaalista toimintaanne (ystävien, sukulaisten, 
muiden ihmisten tapaaminen)? (ympyröikää yksi numero) 
 1 koko ajan 
 2 suurimman osan aikaa 
 3 jonkin aikaa 
 4 vähän aikaa 
 5 ei lainkaan 
 
Kuinka hyvin seuraavat väittämät pitävät paikkansa teidän kohdallanne? 
 (ympyröikää yksi numero joka riviltä) 
   pitää            pitää            en  enimmäk-  ehdotto- 
   ehdotto-      enimmäk-    osaa  seen ei  masti ei 
   masti           seen             sanoa  pidä  pidä 
   paikkansa    paikkansa  paikkansa  paikkansa 
33. Minusta tuntuu, että sairastun jonkin  
verran helpommin kuin muut ihmiset  1 ................2 ................ 3 ............. 4 .................  5 
34. Olen vähintään yhtä terve kuin kaikki  
muutkin tuntemani ihmiset   1 ................2 ................ 3 ............ 4 .................  5 
35. Uskon, että terveyteni tulee 
 heikkenemään   1 ................2 ................ 3 ............. 4 .................  5 
36. Terveyteni on erinomainen  1 ................2 ................ 3 ............. 4 .................  5 
 
